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Protein-protein interactions play important roles in signal transduction, chemical catal-
ysis, cell metabolism, membrane transport, muscle contraction and more. While many of
these interactions can be understood as two-body interactions, other important properties
can emerge when large numbers of molecules interact together. In this dissertation, we inves-
tigate three such systems. We find that a common characteristic in the emergent behavior
is interactions occurring on multiple length and energy scales.
Biomolecular condensates appear throughout the cell serving a wide variety of functions.
Many condensates form by interactions between multivalent proteins, which produce phase-
separated networks with liquidlike properties. We use a model system of poly-SUMO and
poly-SIM proteins in which the basic unit of assembly is a zipperlike filament due to the
interaction of alternating poly-SUMO and poly-SIM molecules. These filaments have defects
of unsatisfied bonds that allow crosslinking for both the formation of a 3D network and the
recruitment of additional molecules, called clients. We observe a nonmonotonic client binding
response that can be tuned independently by the client valence and binding energy. These
results show how the interactions within liquid states can be disordered yet still contain
structural features that provide functionality to the condensate.
The nucleolus is a large membrane-less organelle in the nucleus which is responsible for the
assembly of ribosomes. We have developed models to understand how interactions among
major proteins assist pre-ribosomal assembly and proper rRNA folding in the nucleolus.
The first of these models describes the electrostatic interaction between two major nucleolar
proteins (NPM1 and SURF6-N) as a driving force for the phase separation in the nucleolus.
The second model describes the role of NPM1 as a chaperone in the rRNA folding process.
We have developed analytic, numerical, and computational methods which confirm that
NPM1 lowers the zipper barrier to unzip misfolded rRNA.
Protein aggregation is a major problem in drug formulation for the pharmaceutical in-
dustry. Antibody molecules form elongated complexes due the interaction between their do-
mains. These complexes entangle with each other causing a sharp rise in viscosity of solution.
To reduce the production cost, we need to predict the viscous behavior of molecules in the
early stages of drug development. We develop a method to use dilute solution measurements
to predict the antibody viscosity. We translate the strength of self-association measured by
dilute solution experiments (ACSINS, DLS) into the binding affinity of molecules. A theo-
retical model based on entanglement physics predicts viscosity from these binding affinities.
Predictions are in good agreement with the test set of molecules with a few outliers. Using
the theoretical model, we predict the physical mechanism of these outliers, and we have
proposed solutions to account for these mechanisms in a refined method.
Importance of hierarchical interactions in concentrated protein systems
by
Kamal Bhandari
M.S., Tribhuvan University, Nepal, 2010
A DISSERTATION
submitted in partial fulfillment of the
requirements for the degree
DOCTOR OF PHILOSOPHY
Department of Physics






Dr. Jeremy D. Schmit
Copyright
© Kamal Bhandari 2021.
Abstract
Protein-protein interactions play important roles in signal transduction, chemical catal-
ysis, cell metabolism, membrane transport, muscle contraction and more. While many of
these interactions can be understood as two-body interactions, other important properties
can emerge when large numbers of molecules interact together. In this dissertation, we inves-
tigate three such systems. We find that a common characteristic in the emergent behavior
is interactions occurring on multiple length and energy scales.
Biomolecular condensates appear throughout the cell serving a wide variety of functions.
Many condensates form by interactions between multivalent proteins, which produce phase-
separated networks with liquidlike properties. We use a model system of poly-SUMO and
poly-SIM proteins in which the basic unit of assembly is a zipperlike filament due to the
interaction of alternating poly-SUMO and poly-SIM molecules. These filaments have defects
of unsatisfied bonds that allow crosslinking for both the formation of a 3D network and the
recruitment of additional molecules, called clients. We observe a nonmonotonic client binding
response that can be tuned independently by the client valence and binding energy. These
results show how the interactions within liquid states can be disordered yet still contain
structural features that provide functionality to the condensate.
The nucleolus is a large membrane-less organelle in the nucleus which is responsible for the
assembly of ribosomes. We have developed models to understand how interactions among
major proteins assist pre-ribosomal assembly and proper rRNA folding in the nucleolus.
The first of these models describes the electrostatic interaction between two major nucleolar
proteins (NPM1 and SURF6-N) as a driving force for the phase separation in the nucleolus.
The second model describes the role of NPM1 as a chaperone in the rRNA folding process.
We have developed analytic, numerical, and computational methods which confirm that
NPM1 lowers the zipper barrier to unzip misfolded rRNA.
Protein aggregation is a major problem in drug formulation for the pharmaceutical in-
dustry. Antibody molecules form elongated complexes due the interaction between their do-
mains. These complexes entangle with each other causing a sharp rise in viscosity of solution.
To reduce the production cost, we need to predict the viscous behavior of molecules in the
early stages of drug development. We develop a method to use dilute solution measurements
to predict the antibody viscosity. We translate the strength of self-association measured by
dilute solution experiments (ACSINS, DLS) into the binding affinity of molecules. A theo-
retical model based on entanglement physics predicts viscosity from these binding affinities.
Predictions are in good agreement with the test set of molecules with a few outliers. Using
the theoretical model, we predict the physical mechanism of these outliers, and we have
proposed solutions to account for these mechanisms in a refined method.
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Inter-molecular interactions are crucial for the existence of life because nearly all processes
in biology depends on the intermolecular interactions between macromolecules such as pro-
tein, DNA, RNA and lipids1. These macromolecules interact with each other by a variety
of forces (van der Walls forces, electrostatic forces, hydrophobic interactions, dipole-dipole
interaction, etc.). The structure of molecules and the location of chemical groups encode
binding specificity and catalytic properties. Biomolecules become functional when they in-
teract with binding partners but their functionality may differ depending on their binding
partners and binding locations. The same protein molecule may exhibit different functions
when it interacts with different biomolecules. Interactions at the two-body level are well
studied and their structure-function properties are well understood. However, it is now clear
that many-body interactions are also important in biology.
It has been observed from experiments that some cellular processes may require many
biomolecules. Many cellular structures are formed by the spontaneous condensation of
biomolecules into liquid droplets, often through liquid-liquid phase separation2;3.These con-
densates may contain hundreds of molecules. The molecules that contribute most strongly
to phase separation show high interaction valence and high connectivity to other molecules.
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Many body interactions can also lead to several unwanted outcomes. Protein phase separa-
tion or aggregation as a result of protein-protein interaction can be toxic and cause diseases4;5
including Alzheimer’s disease, Parkinson’s disease , Huntington’s disease, eye lens cataract,
sickle cell anemia, etc. Even in vitro many-body interactions can be important. In drug
formulation, delivery and manufacturing constraints can require very high concentration.
At high concentration, protein-protein interactions can change the solution properties, for
instance, high concentration antibodies will often have very high viscosity. Protein crystals
are also an outcome of protein–protein interaction6. Protein aggregation is another exam-
ple of many-body interactions causing problems in drug formulation for the pharmaceutical
industry.
This thesis is about many-body interactions in biomolecular systems. In the concentrated
regime, biomolecules can interact with each other by different intermolecular interactions.
Here, we focus on two types of many-body systems.
(a) Phase separated condensates: Eukaryotic cells organize biological processes using or-
ganelles, many of these are enclosed by membranes but there are also several that do not
have membranes. Stress granules, nucleoli, P-bodies, cajal bodies, PML nuclear bodies are
some examples of membraneless organelles7–11. While these membraneless organelles have
been known for decades, only recently has it become clear that they have liquid properties
and appear to form by liquid-liquid phase separation2;3. Possible functions for membraneless
organelles includes sequestration of harmful components, storage of useful biomolecules and
speeding up biochemical reactions3;9;12–15.
Membraneless organelles contain tens to hundreds of different biomolecules of which a
few, called scaffolds, are essential for formation of the condensates. Scaffolds also recruit the
remaining molecules, called clients, with the total composition providing functionality7;13. To
explore the physics of membraneless organelles, Rosen and co-workers engineered polySUMO
and polySIM proteins. In the SUMO/SIM system, there are two deccavalent scaffolds,
polySUMO and polySIM, composed of modules connected by short disordeded linkers of
twelve amino acids. In addition, there are low valence SUMO and SIM employed as client
molecules. Rosen and co-workers found that an interesting non-monotonic client binding
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response as a function of scaffold proportions that we are able to explain with our theory.
The nucleolus is one of the largest and most prominent membraneless organelles in the
cell nucleus. The nucleolus has become an attractive system in recent years because it is the
site of major cellular processes such as DNA transcription, RNA processing, pre-ribosomal
assembly16–18 etc. The nucleolus has three sub-compartments with known function19. DNA
transcription to produce rRNA occurs at the central layer, rRNA pre-processing and mod-
ification occurs in the middle layer, and the outermost layer assembles ribosomal subunits.
The major biomolecules involved in pre-ribosomal assembly are NPM1, SURF6 and rRNA.
After assembly in the nucleolus, ribosomal subunits are exported to the cytoplasm where
they form a mature ribosome. Ribosomes produce proteins in the form of a linear chain or
random coil of polypeptides20.
(b) Formulation of antibody: Therapeutic anitbodies have been developed to treat several
human diseases21;22 and their importance has grown day by day. Subcutaneous adminis-
tration is the favored method of drug delivery to patients with chronic diseases for which
frequent dosing is necessary. Limited volume available in the subcutaneous space requires
high concentrations of antibody drugs, which can lead to the high viscosity23. The high vis-
cosity not only increases the injection time but also pain at the injection sites24. Hence, high
viscosity of antibody formulations is a major problem in drug development. There are many
factors that affect the viscosity of protein solution, such as concentration, pH, ionic strength,
charge, shear rate, temperature, molecular shape, and protein-protein interactions25–28. We
need to understand the physical mechanisms of high viscosity to provide guidance in drug
development. It is difficult to mitigate high viscosity once a drug is developed, therefore,
successful prediction of viscosity at early stages of development would reduce manufacturing
costs. There are several existing computational and experimental tools to predict antibody
viscosity. Existing computational tools have very low resolution because they use machine
learning techniques or empirical methods to predict viscosity. Existing experiments measure
the strength of interaction in dilute solution (two-body effects) but have difficulty accounting
for many-body interactions that drive viscosity. Here, we develop a method that connects
the two-body measurements with many-body viscosity.
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Despite the major difference in these systems, a common theme has been emerged. We
find that in all cases we study, important properties emerge from the combination of two-body
interactions and mony-body interactions. Experiments performed at the scale of two-body
interaction cannot explain many-body properties and the experiment at the scale of many-
body interaction cannot account for two-body effects. We study here the combined effect of
these multiple interactions on three different systems. As a result of the multiple interactions,
these system have a hierarchical structure,i.e., strong interactions form molecular complexes
and weak interactions drive many-body effects.
1.2 Dissertation outline
In chapter two, we study the assembly of SUMO/SIM condensates, a synthetic system de-
signed to explore the properties of membrane-less organelles.
Chapter three explores how the concurrent pre-ribosomal assembly and rRNA folding
process occurs in the nucleolus. In this chapter, we briefly explain how a protein (NPM1),
drives the phase separation and acts as the chaperone for rRNA folding.
In chapter four, we discuss how dilute solution measurements can be used as an effective
way to predict antibody viscosity at early stages of drug development. We have developed
an hypothesis that connects dilute solution measurements (two-body effects) to the viscosity
(many-body effects) of the molecules.






The human body is comprised of trillions of cells. Each cell has numerous organelles which
perform various functions. Many of these organelles in eukaryotic cell are not enclosed by
a membrane, for instance, Stress granules, Nucleoli, P bodies, Cajal bodies, PML nuclear
bodies and so on7–11. These cellular bodies are micron-sized assemblies of protein and often
RNA found in cytoplasm and nucleoplasm2;29. The function of membraneless organelles are
still unclear but it is hypothesized that cells produce them in order to concentrate biochemical
reactions, to sequester harmful components, to store of useful bio-molecules, and to enhance
signaling pathways3;9;12–15 . Many of them display the liquid-like properties, such as, spherical
shape, the ability to flow and they coalesce upon contact with each other3;29.
These properties along with the observation that they form by the spontaneous con-
densation of bio-molecules, has led to the suggestion that they are a form of liquid-liquid
phase transition2;3. Liquid-Liquid phase separation (LLPS) is a thermodynamically driven
phenomenon in which a homogeneous solution of molecules separates into two distinct liq-
uid phases, with different solute concentrations. In LLPS, molecules can diffuse within the
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dense phases or between the dense and dilutes phases because these phases are in equilibrium.
LLPS depends mainly on the temperature, type and concentration of molecules, and interac-
tion among solute and solvent molecules. While these condensates may contain hundreds of
different molecules, typically only a small number of molecules with high interaction valence
and high connectivity to other molecules contribute strongly to phase separation30–32. These
are said to have “scaffold-like” properties depending on how strongly they promote phase
separation. They are main components essential for structural integrity of cellular bod-
ies. In another words, they are building block of cellular bodies. The remaining molecules,
which exhibit “client-like” properties, are recruited through interactions with scaffolds7;13.
Together, the collection of molecules in a condensate determines its functionality.
Since the molecules driving phase separation are multivalent, polymer-like species, many
treatments of condensate formation are based on polymer theories5;33–35. In particular,
scaffold condensation can be understood as the interaction between attractive “stickers”
separated by inert “spacers”35;36. These efforts explain universal features of condensates,
such as how multivalency can amplify the effect of weak interactions to tune the phase
coexistence line to lie within physiologically relevant regions of phase space (e.g. physiological
concentrations)5. However, condensates have been shown to perform diverse functions, and
the evolutionary pressure to optimize these specific functions implies that there will also
be non-universal features3;9;12–15. This begs the question of how the disordered network of
interactions within a liquid structure can affect its properties.
The disorder in biomolecular condensates poses a challenge for structural biology to
determine what features of the assembly are functionally relevant. In previous work, our
research group showed that analytic theory can be used to deduce structural features in
these systems8. This approach is analogous to conventional methods like NMR and crys-
tallography in that experimental constraints are used to refine a structural model. A major
difference is that the model does not specify spatial coordinates, but instead, describes the
network connectivity. This is encoded in a free energy model that uses system-specific order
parameters to capture structural features as well as regions that remain disordered.
Here we apply this approach to condensates formed by poly-SUMO and poly-SIM, a
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Figure 2.1: Phase diagram displays client recruitment. The assembly of scaffolds (poly-
SUMO/polySIM at different stoichiometric ratios) recruits the client (red fluorescently la-
beled protein SIM, 100 nM). The client recruitment is observed only on the side of diagonal
where its cognate scaffold was in stoichiometric excess in solution. Adapted with permission
from Banani et al. Copyright 2016 by the Cell.
synthetic system composed of repeating units of either SUMO or its binding partner, SIM,
that was developed to study the recruitment of client molecules (Fig 2.1)7. In SUMO/SIM
system, scaffolds of the same kind do not interact and undergo phase separation, so that only
mixture of both scaffolds, poly-SUMO and poly-SIM, form condensates7. SUMO is the Small
Ubiquitin-like Modifier protein which has ∼ 100 amino acids and ∼ 12kDa molecular weight,
and SIM is SUMO Interaction Motif which has ∼ 23 amino acids and ∼ 3kDa molecular
weight. poly-SUMO and poly-SIM both are formed by ten repeats of SUMO protein and SIM
protein respectively. In both poly-SUMO and poly-SIM, the modules are separated by a Gly-
and Ser-rich short, disordered linker of 12 amino acids. SUMO protein has folded domain
while SIM is the intrinsically disordered protein. This system captures the features of the
common sticker-and-spacer topology, and the 1:1 binding stoichiometry between SUMO and
SIM modules eliminates the ambiguity in identifying the sticker moieties that complicates
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the study of natural systems. The experimental system also includes constructs containing
only 1, 2, or 3 SUMO or SIM repeats, which one considered to be clients of the SIM and
SUMO scaffolds respectively.
We find that SUMO/SIM condensates have a zipper-like microstructure that differs from
the brush-like microstructure of SPOP/DAXX or the random network of FUS-like pro-
teins8;35. This microstructure dictates how client recruitment varies with changes in valence
and affinity, and suggests that the composition, and thus function, of a condensate can
be changed through modulation of its internal structure independent of its propensity to
undergo phase separation. These results show how functionally relevant structures can be
embedded within liquid-like disorder.
Based on these results, we propose a general model in which functional properties emerge
from hierarchical assembly within a condensate. In this model, strong interactions drive the
formation of molecular complexes with functional properties. These complexes then condense
into a fluid state via weaker interactions. This combination of strong and weak interactions
combines the best features of both interactions modes. Strong interactions provide the
structural specificity needed for functional properties to emerge, while weaker interactions
allow the formation of a high density state without the kinetic arrest that would accompany
assembly driven strictly by strong interactions.
2.2 Methods
2.2.1 Zipper-like filaments allow most modules to form bonds
within a sparse network.
Our initial attempts to model SUMO/SIM condensates employed Flory-Huggins theory with
three components representing SUMO, SIM, and solvent. Flory-Huggins is a lattice mean-
field model representing a maximally disordered system. We refer to Flory-Huggins and
similar theories for associative polymers35–37 as “random network” models, reflecting the
fact that each binding site randomly searches the nearby volume for interaction partners,
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which results in uncorrelated binding. The Flory-Huggins lattice constant is determined
by the dimensions of the macromolecular repeat units. In this case, estimates for the linker
radius of gyration and module size yield repeat units on the order of 3 nm. We found that any
realistic combination of interaction parameters, which account for excluded volume, binding
energies, and spacer entropy, yields lattice occupancies of at least 70%, and usually much
greater. With a 3 nm lattice constant, this corresponds to a droplet module concentration
on the order of 50 mM, much greater than the observed concentration of ∼ 2 mM7. To
account for the finite valence of the SUMO and SIM modules, we modified our model for
SPOP/DAXX assemblies to account for decavalent scaffolds and, again, obtained results
consistent with a dense phase module concentration near 50 mM. Electrostatic repulsion
was considered as a swelling mechanism and rejected on the grounds that the repeat unit
dimensions are greater than the ∼ 1 nm Debye screening length, which eliminates long range
interactions (short range effects are accounted for in the module binding affinity).
Gap Defects
Sticky End Defects
Figure 2.2: a) Random crosslinked-like structure. b) Zipper-like structure.
The experimentally measured module concentration implies that the volume per decava-
lent scaffold is (2 nM/10)−1 ' (20 nm)3. Since, this is larger than the random walk volume
of a scaffold, this separation would allow only a small fraction of intermolecular bonds to be
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satisfied if the molecules are randomly oriented. For bond energies strong enough to drive
phase separation, on the order of kBT , the penalty for this many unsatisfied bonds is pro-




(a) Scaffolds and clients
Gap defects
Clients
Overlap defect (not considered)
(b) Zippers and defects





Figure 2.3: Poly-SUMO and poly-SIM assemble into zipper-like filaments. (a) SUMO/SIM
droplets are composed of decavalent scaffolds and clients of valence 1, 2, and 3. (b) Inter-
molecular bonding is most efficient when the scaffolds align to form zipper-like structures.
The zippers have bonding defects including sticky ends and gaps. Overlap defects are also
possible but neglected in our calculation. (c) Zipper defects provide binding sites to recruit
clients or (d) assemble the zippers into a 3D network. The short linker connecting modules
favors consecutive bonds with the same molecule rather than the formation of a random net-
work.
The alternative to randomly oriented scaffolds is that SUMO/SIM networks satisfy most
binding sites by aligning the scaffolds (Fig 2.2b). Therefore, we developed a theory to
describe aligned molecules. Fig. 2.3a,b shows a model where the molecules are aligned to
form zipper-like structures. By comparing the predictions of this model to the experiments
of7 we can learn the extent to which this “zipper model” describes SUMO/SIM condensates.
Thermal fluctuations require that SUMO/SIM zippers will have defects in the bonding
structure that provide recruitment sites for clients as well as enable the 1D filaments to
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assemble into a 3D network (Fig. 2.3c,d). Therefore, the properties of the zippers determine
the properties of the larger scale droplets. Notably, the defects will have a spacing on the
order of the scaffold dimension, consistent with the (20 nm)−3 scaffold concentration. Fig.
2.3b shows two defects considered in this work, gaps and sticky ends, as well as an overlap
defect that we neglect. Overlap defects incur a binding energy penalty identical to a gap,
but are further suppressed by the steric clash between the two modules competing for the
same binding partner. Therefore, we expect, and our results confirm, that sticky ends and
gaps are the dominant defect in the zipper structure.
2.2.2 The filament partition function can be calculated with trans-
fer matrices.
Due to the 1D nature of the zippers, their properties can be conveniently calculated using
a transfer matrix formalism38;39. To illustrate this approach, consider a tetravalent (v = 4)
system (in subsequent calculations we use v = 10 to compare to the experiments of7) and
define QN(j) as the partition function of a filament containing N molecules that terminates
with a sticky end of j unpaired sites. Next, we construct a v− 1 dimensional vector, V(N),
whose elements are the statistical weights QN(j) for sticky ends of each length, j. This vector
obeys a recursion relation V(N + 1) = MiV(N), where the transfer matrix Mi generates






















where ε is the SUMO-SIM binding free energy (all energies are expressed in units of kBT )
and zi is the fugacity of the added molecule. Matrix elements below the antidiagonal leave
gap defects which can bind clients or form crosslinks with other filaments. This is accounted
for by the gap partition function gi(m), where m is the size of the gap. Since we have
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two scaffold molecules, the grand partition function for a filament of N + 1 poly-SUMO
and N + 1 poly-SIM molecules can be generated by alternately applying the matrices for
the two species and applying vectors VL/R to collapse the matrix product into a scalar
polynomial (see Appendix). This operation is given by QN+1 = VL(MUMI)
NVR, where the





















Figure 2.4: Model parameters are obtained from poly-SUMO/poly-SIM dimerization exper-
iments. Plot of the dimer association constant, K2v, vs. the valence, v. The module binding
free energy, ε, is obtained from the slope of lnK2v (blue line), while the intercept provides
the reference concentration c0. Clients (mono-, bi-, or trivalent SIM) have a lower binding
affinity than scaffolds in the droplet phase, which we attribute to steric interactions between
the network and the fluorescent labels. We account for this with a free energy offset, fRFP,
for clients in the dense phase (purple line).
The most important parameter in Eq. 2.3 is the module binding affinity ε, which can
be obtained from dilute solution measurements7 as follows. Consider the dimer associa-




Appendix), where c2v is the concentration of scaffold dimer. Here the reference concen-
tration c0 gives the equilibrium constant appropriate units and enters the matrix formal-
ism through the fugacity zi = ci/c0 (valid for dilute solution when the monomer free en-
ergy is set to zero). The dimerization free energy is given by the dimer partition function
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e−∆F2 = e−vε(1 + 2eε + . . .+ 2e(v−1)ε), where the terms represent the perfectly aligned state
and successively larger mis-alignments. Plotting lnK2v vs. v (Fig. 2.4), we can extract
ε = −2.23 kBT from the slope and c0 = 64 µM from the intercept. Note that ε accounts for
both the binding affinity between modules, as well as the entropic cost of constraining the
connecting spacers.
To compute solution properties we construct the grand partition function









where the first two terms represent the monomers, the third term represents the perfectly
aligned dimer, and the two sums represent filaments starting with SUMO and SIM respec-
tively. The matrices Mi and end vectors V are given in the Appendix.
2.2.3 Transfer matrix formalism enumerates all the ways to assem-
ble a 1D filament of alternating poly-SUMO and poly-SIM
molecules.
Transfer matrices are the technique to compute the interaction between nearby locations in
1D systems. In Quantum Mechanics, transfer matrices are used to compute 1D wavefront.
Here, we apply them to compute the partition function of scaffold chains. In another words,
when a scaffold is added in scaffold complexes of order n, transfer matrix accounts all possible
ways of n+1 order scaffold assembly formation. Transfer matrix conveys all information
about scaffold-scaffold binding, defect sites and scaffold-client binding.
A graphical representation of transfer matrix for poly SUMO (four repeats of SUMO)/poly
SIM (four repeats of SIM) is shown in Fig 2.5.
The column vector in the right hand side of Fig.2.5 represents the end state of a scaffold
filament which has three possible state overlaps. The red overhang allows further growth.
The next blue scaffold can bind to the red overhang in up to three possible ways (shown in




Figure 2.5: The graphical representation of transfer matrix: Transfer matrix generates the
possible states upon the addition of a molecules to the filaments.
possibilities are depicted in the matrix elements. After the blue molecules is added, there are
again three possible states for the ends of the filament, which are depicted by the cartoons
in the left vectors.
Figure 2.6: First Possibility: The added blue scaffold may occupy all three end defects on
the red scaffolds.
To determine the statistical weight of each molecules addition event, we consider each of
the outcomes for a starting overhangs of three units. The first possibility is that each of three
sticky end defects are occupied by blue scaffold (Fig.2.6). This does not create gap defect
and blue scaffold now has only one new sticky end defect (see Fig.2.6). The corresponding
matrix elements is given by zi exp
−3ε.
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Figure 2.7: Second Possibility: The added blue scaffold may occupy two of three end defects
on the red scaffolds.
In the second possibility, just two of three red sticky ends are occupied by blue scaffold
(Fig.2.7). Here, assembly create one gap defect and blue scaffold currently has two new
sticky end defects (see Fig2.7). The corresponding matrix element is given by zi exp
−2ε gi(1)
where gi(1) is the gap partition function for a single defect in the filament which we discuss
in next section.
Figure 2.8: Third Possibility: The added blue scaffold may occupy only a defect on the red
scaffolds.
The final possibility, only one of the three red sticky end defects are occupied by the
blue scaffold (Fig.2.8). This outcome creates two gap defects and the blue scaffold now has
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three new sticky end defects (see Fig.2.8). The corresponding matrix element is given by
zi exp
−ε gi(2) where gi(2) is the gap partition function for two defects in the filament (see
next section).
These three cases give last column components of transfer matrix. Similarly, we can write






















Since we are examining the client binding behavior with an arrangement of polySUMO
and polySIM, both have ten repeats of scaffolds, we need transfer matrix for poly SUMO
(ten repeats of SUMO)/poly SIM (ten repeats of SIM) system which is shown in Appendix.
2.2.4 Clients can bind to filament defects.
We next examined how the structural properties of scaffold assemblies in the droplet and
bulk phases influence partitioning of mono-, di-, and trivalent SIM molecules employed as
clients by Banani et al.7. In particular, we sought to understand the curious observation that
high-valence clients show non-monotonic partitioning behavior as the SUMO/SIM scaffold
ratio changes7. To account for the recruitment of clients to the droplet we add client binding
to the gap partition function. The form of the gap partition function depends on the valence
and the concentration, ccl, of the clients as follows.
a) Monovalent Client: Monovalent clients can occupy any defect in the filament. We
consider each monovalent client can occupy these defects independently. In case there are
m defects in the filament, total gap partition function for monovalent clients is given by
g(m) = (1 + (ccl/c0)e
−(ε+fRFP))m (2.4)
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Figure 2.9: Monovalent Clients occupy the defects independently.
First terms in gap partition function stands for a defect not occupied by a monovalent
client and the second term stands for the deformity occupied by monovalent client. While
the binding energies in Eq. 2.4 is same as those for the scaffolds due to the same underlying
SUMO-SIM interaction, the binding affinity of clients is lower in the droplet than in the
bulk7. We attribute this to the entropy cost of confining the bulky RFP fluorescent tag
within the droplet network. This steric penalty is included in our model with the factor
fRFP. A least squares fit of the client partitioning yields fRFP = +3.15 kBT (Fig. 2.4). fRFP
is the only free parameter in our model.
b) Divalent Client: Divalent client occupy two defects. If there is only one defect in a
scaffold, it can not be occupied by divalent clients. But if there are two or more defects in
row, none of them might be occupied or the defects sites could bind any number of divalent
client up to the half of the defects. If a scaffold has m defects, they can bind 0, 1, 2...m/2
















is the total number
of ways Nc divalent client could be bound with m defects. This degeneracy factor is com-
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puted below.
Figure 2.10: Divalent Client: The binding entropy of the clients in a gap arises from the
degeneracy of arranging the clients and unbound sites.
c) Trivalent Client: Trivalent clients require three or more defects in row. If a scaffold
has m defects, they can bind 0, 1, 2...m/3 trivalent clients. For a given number of m defects,
















is the total number
of ways Nc trivalent client could be bound with m defects.
In conclusion, each gap site is independent in the case of monovalent clients, which gives
a simple binomial with the two terms representing the empty and client-bound states. For
multivalent clients we have the more involved process of counting the number of ways to
add Nc clients to m sites and summing over the number of clients that will fit in a gap.
The binding entropy of clients in a gap arises from the degeneracy of arranging the clients
and unbound sites. We can treat the clients and vacancies as two particle types. When Nc
clients of valence v bind to a gap of m sites, there are Nv = m − vNc unoccupied sites. So
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Figure 2.11: Trivalent Client: As client valence increases the binding entropy of clients in
a gap decreases.
the total number of particles is Nt = Nc+Nv = m− (v−1)Nc. The number of permutations
is, therefore, the number of ways to select Nv particles from Nt positions. This degeneracy
gives the binomial coefficients appearing in Eqs. 2.5 and 2.6.
2.3 Results
2.3.1 The condensed phase has structural features emerging on
different length scales.
On length scales larger than the scaffold dimension the droplet resembles a random network
of zippers (Fig. 2.3d). On this scale the only structural feature is the mesh size, which is
determined by the crosslink density. Since the zipper motif fully satisfies the SUMO and
SIM binding sites, the crosslinks can only form at defect sites. This limits the affinity of
crosslink bonds, so the crosslinks are relatively weak and rapidly break and reform due to
thermal fluctuations. This rapid reconfiguration is responsible for the liquid properties of the
dense phase. In contrast, the cooperative binding within the zipper gives them a persistent
structure that provides crucial functional characteristics. The zippers have considerable
19
disorder, due to the many ways that the scaffolds can be aligned, but the essential structural
features can be described by two quantities.
Defect density
The first is the defect density, which describes the capacity of the filaments to bind clients
or crosslink into a 3D network. Using the substitution gi(m) = g
m so that g is the statistical
weight of an unbound module, the density of unpaired sites per scaffold molecule is given by
ρg = N
−1
tot g∂ lnQ/∂g. This gives ρg ' 0.6 unbound sites per decavalent scaffold at equimolar
























Figure 2.12: Filament length and defect density depend on stoichiometry. (a) At equal
stoichiometry most scaffolds are fully bound resulting in few defects. As the stoichiometric
imbalance increases, the number of unbound SUMO modules increases while the number of
unbound SIM sites decreases.
Using this defect density, the zippers can be described in the sticker/spacer framework
where the defects are stickers and the spacers are zippers with a length of 10/ρg ' 17
modules. The expected radius of gyration of these spacers is ∼ (3 nm)
√
17 ∼ 12nm, which
is consistent with, but somewhat smaller than, the 20 nm average molecular spacing. If we













Weighted 0.59 1.25 1.76 2.09 2.31
50 60 70 80 90
SUMO Module Concentration(µM)
Table 2.1: Average SUMO/SIM defect density
to radius of gyration (∼ 12nm), it gives the expected droplet density (∼ 4500µm). The
experimental droplet density is about 2500− 2900µm. We attribute this discrepancy to the
fact that not every defect will be involved in a crosslink and zippers will be less flexible than
individual scaffolds due to the double linkage and increased charge density, so the spacer
radius of gyration will be larger than our 12 nm estimate.
Total average length of zipper
The second useful quantity to describe the zipper structure is the average number of scaffolds
in a zipper. Here, we calculate the length of chain/assembly as the function of scaffold module
concentration. Since related exploratory work7 has done in certain scaffold concentration
range, polySUMO and polySIM sfaffold module vary from 50µM to 90µM in our calculations.
Calculation: Total grand partition function for zipper like structure is:































































Figure 2.13: Scaffold stoichiometry determines the average number of SUMO/SIM scaffolds
in the assembly.
Fig.2.13 and Fig.2.14 give average number of SUMO/SIM molecules and total average
length of an assembly for fixed SIM module concentration 50 µM and SUMO module con-
centration ranging from 50 µM -90 µM . For equal module concentration(50 µM SUMO/50
µM SIM), average number of molecules for both scaffold per assembly are equal and high
i.e. chain length is long because both scaffold are sufficient to bind each other. There is no
restriction to make chain through scaffold proportion. They make assembly longer up to the
point where binding interaction is sufficient to pay the entropy cost of recruiting additional
scaffolds. But as we go off slightly from equal module mixing (increase SUMO module con-
centration keeping SIM module fixed), average number of SUMO molecules per assembly
increases because excess module quickly finds one of the sticky ends but average number of
SIM molecules per assembly decreases. At higher scaffolds inequality, lower concentration
SIM scaffolds have to bind more highly concentrated SUMO scaffolds which is possible only
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Figure 2.14: The average length of filaments is a non-monotonic function of scaffold
stoichiometry. A small excess of one scaffold leads to an increase in the filament length
because unpaired scaffolds are available to stabilize sticky ends resulting from mis-aligned
states. Larger stoichiometric mismatches result in a decline in filament length, which provides
more sticky ends to bind the excess scaffold.
when the chains become more shorter. Our calculation shows that low concentration scaf-
folds can bind more of the high concentration scaffolds when chains become shorter. For
example, four red scaffolds can bind five blue scaffolds in a single chain but same number of
red scaffolds can bind eight blue scaffolds when forming many short chain (Fig.2.15).
Shorter Chain
Longer Chain
Figure 2.15: Larger stoichiometric mismatches prefers the shorter chain.
In conclusion, the most energetically favored state is the perfectly aligned dimer which
allows all binding sites to be satisfied (Fig. 2.3b). This competes with the misaligned states,
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which have a higher entropy due to the many possible alignments. This is particularly true
upon the formation of filaments with Ntot ≥ 3 because the unpaired sites can be distributed
throughout the filament rather than localized at the ends. At sufficiently high concentration
the entropic gain of misalignment can overcome the energetic cost of defects allowing the
formation of large assemblies.
2.3.2 Asymmetric scaffold stoichiometries promote filaments over
perfectly aligned dimers.
Monomer concentration variation
SUMO and SIM scaffolds interact and form filament assemblies. These filaments forms
droplet of higher density and leave other scaffolds in the dilute phase. Free monomer con-
centration varies with different ratios of scaffold mixing. Here we discuss the monomer
concentration variation for different scaffold module concentration ratios.
Calculation: The grand partition function for azipper is:









The total module concentraion of SUMO and SIM can be written in the following form from









For given value of discrete SUMO/SIM total module concentration, we have calculated
the monomer concentration for both SUMO/SIM scaffold (Fig.2.16). We observe from the
figure that
(a) If SUMO and SIM have equal module concentration, their monomer concentrations are
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equal but it is low (∼ 10−11) in comparison to module concentration(∼ 10−6).
(b) If there is asymmetry in Scaffold mixing, monomer concentration for the lower concen-
tration scaffold decreases (∼ 10−15) whereas the higher concentration scaffold’s monomer
concentration increases (∼ 10−6).
Sumo
SIM














Figure 2.16: Monomer concentration variation: Excess SUMO scaffold accumulates in
dilute phase and depletes the concentration of monomeric SIM scaffolds
It is observed from Fig.2.17 that chain length is long for equal module concentration. In
case there is a slight disparity in scaffold proportion, the abundance monomer quickly binds
with the assembly so that the chain length increases but if we increase further inequality in
scaffold mixing, lower concentration scaffold tries to bind as much as higher concentration
scaffold making chain length shorter and shorter but if there is large inequality in mixing,
lower concentrated scaffold are not adequate to bind more higher concentrated scaffold even
in the form of shortest assembly so that unbound higher concentration scaffold remains in
the solution.
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Large Inequality Small Inequality
Equal Module Very Small Inequality
Figure 2.17: Larger stoichiometric mismatches not only shortens the assembly length but
also leaves the large portion of free monomer in the solution.
Perfectly aligned dimer concentration variation
While writing up the grand partition function of our model, we have referenced that that
there is plausible of both scaffold to be perfectly aligned. Numerically it is addressed by
exp−nε cIcU .
For a fixed SIM module concentration [50µM ] and SUMO module ranging from 50µM −
90µM , the perfectly aligned dimer concentration variation is shown in Fig.2.18. It is ob-
served that this perfectly aligned dimer concentration is high for equal scaffold mixing but
that concentration decreases in case of scaffold inequality. This is because at equal module
concentration even N-mers are more favorable than odd N-mers. Among all even N-mers,
perfectly aligned dimer is most favorable. But at an unequal module concentration, odd
N-mers are more favorable than even N-mers.
Higher N-mers concentration variation
The assemblies of scaffolds contain higher N-mer terms (imperfectly aligned dimer, trimer,
tetramer, pentamer, hexamer, heptamer etc). Here we have studied their concentration
variation in both cases of equal and unequal scaffold mixing.
Fig. 2.19 shows the higher N-mers concentration for fixed SIM concentration [50µM ]
26































Figure 2.18: Perfectly aligned dimer concentration variation: equal module mixing favors
the perfectly aligned dimer whereas stoichiometric mismatches depletes their concentration.























Figure 2.19: Nmers concentration variation: filament with equal number of SUMO and
SIM scaffolds are favored at symmetric mixing but unequal stoichiometries favors odd length
filaments.
27
and variable SUMO concentraion (ranging from 50µM − 90µM). For equal module mixing
[ SUMO[50µM ] and SIM[50µM ]], even N-mers are more favorable than odd N-mers in light
of the fact that more binding interaction is achieved. We have to keep in mind that total
free energy of system not only depends on the free energy due to the binding interaction
but also on free energy due to entropy. Among even N-mers, perfectly aligned dimer is most
favorable because maximum binding interaction is accomplished. The hierarchy of remaining
even N-mers depends of their length. If length increases, they are less favorable because they
have to pay more entropy cost to sustain their length.
At unequal module concentration, odd N-mers are more favorable than even N-mers
because odd N-mers get additional free energy due to entropic arrangement than even N-
mers. There are excess monomers in the solution at unequal module concentration so that
excess monomers bind with assembly without paying any entropy cost. The hierarchy of odd
N-mers relies upon scaffold module proportion, i.e., scaffold module proportion determines
the favorable odd N-mers size with which free energy of the system is least. It is observed
that small sized odd n-mers are more favored as we go to large scaffold inequality.
Studying all these concentration mentioned above, it is concluded that the combined
behavior of the defect density and the filament length can be understood by looking at the
populations of different filament lengths (Fig. 2.19). At equal stoichiometries, the solution
is dominated by perfectly aligned dimers resulting in a small average complex size. This
is similar to the “magic number” effect seen in the simulations of EPYC1 and Rubisco
in which phase separation is inhibited when the concentration and valence of scaffolds are
matched40;41. At unequal stoichiometries the energetic penalty for misalignments is reduced
because excess scaffolds are available to bind one of the sticky ends, which facilitates the
formation of longer complexes. As the stoichiometry mismatch increases, the system becomes
dominated by odd-length complexes which are initially large before trimer (2:1 stoichiometry)
states dominate at large stiochiometric mismatches. The decrease in filament size at large
stoichiometric asymmetry can be understood as an abundance of filaments that have two
sticky ends of the same type, which prevents them from joining into larger assemblies. The
shortening of filaments causes an increase in sticky ends and, therefore, an increase in the
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concentration of defect sites (Fig. 2.12a). The defect density increases rapidly at first, then
slows at SUMO module concentrations above 70 µM as the 2:1 trimer begins to dominate.
2.3.3 Asymmetry in scaffold stoichiometry can only be accommo-
dated at the filament ends.
Our matrix formalism does not allow for direct calculation of the assembly of filaments into
a 3D network within the droplet. However, we can compute the ratio of SUMO to SIM
scaffold in the droplet by assuming that the monomer and perfectly aligned dimer remain in
the bulk solution, Qdilute = cU + cI + cUcIe−vε, while all other complexes are in the droplet,
Qdroplet = Q − Qdilute. The calculated stoichiometry is compared to the experimentally
measured droplet composition in Fig. 2.20a. The droplet SUMO/SIM ratio has downward
curvature indicating that the droplet is unable to accommodate the stoichiometry mismatch
of the bulk solution. This is a consequence of the filamentous structure because the interior
of the filament is constrained to a 1:1 stoichiometry, so stoichiometric imbalance can only be
accommodated at the filament ends. The filament calculation has somewhat more curvature
than the experimental ratio (Fig. 2.20a, solid line) suggesting that the approximation of
purely 1D assembly breaks down when the SUMO/SIM ratio is greater than ∼ 1.4. The
cause of the failure emerges upon comparing the monomer scaffold concentration (Fig. 2.16)
to the binding affinity of the modules, K1a = 10
5 M−1 7. This comparison reveals that when
the SUMO concentration exceeds 80 µM the monomer concentration is sufficiently high that
scaffold binding to gap defects cannot be neglected. A simple correction, allowing monovalent
binding to the gap defects (see Appendix), resolves the discrepancy (Fig. 2.20a, dashed line).
This calculation provides a valuable consistency check for our model. It shows that below
80:50 SUMO/SIM ratios the 1D zipper model provides an excellent representation of the
droplet. However, above this ratio the 1D model will underestimate the SUMO scaffold
content.
A related calculation is to compare the scaffold partition coefficient (PC), defined as

















Figure 2.20: Model captures the droplet scaffold composition observed in experiment. (a)
The ratio of poly-SUMO to poly-SIM (NU/NI) calculated from our theory agrees well with the
droplet stoichiometry in experiments. At high stoichiometric mismatches the approximation
of purely 1D filaments breaks down because the concentration of free scaffolds is high enough
to allow binding in the gaps. A correction accounting for monovalent scaffold-gap binding
(inset cartoon) resolves the discrepancy with experiment (dotted line). (b) Small stoichiomet-
ric mismatches promote increased scaffold accumulation in the droplet phase, but the trend
reverses as the average filament size drops. The discrepancy at 90 µM can be explained by
a breakdown of the 1D approximation as depicted in the cartoons of panel (a). In all panels
lines indicate theory and circles denote the experiments of Banani et al.
tional composition in each phase is Ni/(NU + NI), where i = U or I. In order to compare
with experiments we weight this quantity by the experimentally determined total module









where [Cbulktotal] and [C
droplet
total ] are the total module concentration in bulk and droplet phase
respectively7. The initial rise in the scaffold partitioning is due to the increase in filament
lengths, but the trend reverses with the accumulation of smaller filaments at large stoichio-
metric asymmetry. The excellent agreement between theory and experiment without free
parameters provides strong evidence supporting the zipper structural model. Notably, the
partition coefficients in Fig. 2.20b underestimate SUMO recruitment at 90 µM, which is
consistent with the breakdown of the 1D model observed in Fig. 2.20a,b.
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2.3.4 Filament defects compete with soluble scaffold molecules
for client binding.
The condensate formation due to the assembly of scaffolds might have two sorts of deformi-
ties. These defects are either end defects or gap defects. Clients are bound in these defects.
Not all clients bind in defects, it depends on their binding affinity. In this segment we will
sort out the extent of clients dividing into condensate and bulk.
Client partition coefficient is defined as the ratio of the concentration of client into the
droplets to the concentration of client in bulk.
Mathematically it is represented as
PC =
Concentration of client in droplets
Concentration of client in bulk
(2.14)
The schematic representation of PC is
Figure 2.21: Schematic represenation of PC
Total concentration of client in condensates is the sum of concentration of free clients in
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condensate and concentration of client bound in the defects. Similarly, total concentrations
of clients in the bulk is the sum of concentration of free client in bulk and the concentration
of clients bound with scaffolds remaining in the bulk.
PCcl =
[C freeclient]droplet + [C
bound
client ]droplet




where [C freeclient]droplet = [C
free
client]bulk are the free client concentrations in the droplet and bulk,
respectively, and [Cboundclient ]bulk and [C
bound
client ]droplet are the bound client concentration in the bulk
and droplet phase, respectively. Here, we have assumed that the monomer and perfectly
aligned dimer remain in solution/bulk state whereas the imperfectly aligned dimer and all
other longer complexes are in the droplets.
The total grand partition function of bulk/solution state is given by
Qsolution = Qmono +Qdimer
where first and second term are partition function for monomer state and perfectly aligned
dimer state respectively.
Similarly, grand partition function for assembly state is total grand partition function
minus grand partition function of solution i.e.
Qassembly = Qtotal −Qsolution
The average number of bound clients per scaffold is computed as ρc = N
−1
tot ccl∂ lnQdroplet/∂ccl.
The bound client concentration is obtained by multiplying ρc times the experimentally de-
termined scaffold concentration7 which is shown in Table 2.2. Similarly, the bound client
concentration in the dilute phase [Cboundclient ]bulk can be calculated from the total number of
clients per scaffold in the dilute phase multiplied by the corresponding scaffold monomer
concentration in the bulk phase.
Note that the concentrations cU, cI, and ccl appearing in the partition functions all
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SIM Module Concentration(50µM)
2479.6 2720.2 2885.1 2856.5 2889
50 60 70 80 90
SUMO Module Concentration(µM)
Table 2.2: Experimental SUMO module concentration in droplets
represent the concentration of molecules that have not formed intermolecular bonds. These
values must be determined by numerically solving the equations Ctot = ci∂Q/∂ci for scaffolds
and Ctot = ccl + φC
bound
droplet + (1 − φ)Cboundbulk for the client. Here Ctot is the total (bound and
unbound) concentration of the relevant molecule and φ is the volume fraction occupied by
the droplet phase. The droplet volume fraction can be determined from the experimental
values7 of the dilute and droplet protein concentrations using Ctot = φCdroplet +(1−φ)Cdilute.
The client partitioning provides further evidence for our structural model (Fig. 2.25). The
1D calculation captures the relative peak heights and locations, neither of which are sensitive
to the free parameter. With the aid of a free parameter, the calculation quantitatively agrees
with experiments for SUMO concentrations less than 80 µM. Above this concentration, the
calculation systematically underestimates client recruitment, which again is consistent with
increased SUMO scaffold content as the 1D approximation fails.
Monovalent client
We have calculated the monovalent client (SIM1) partition coefficient for different scaffold
concentrations shown in Fig. 2.22. It has been observed from Fig. 2.22 that,
1) PC is low for equimolar mixtures of scaffolds.
2) PC increases for small excess of the complementary scaffold and then begins to diminish
gradually at higher scaffold inequality.
Our calculation closely agrees with experimental PC7. While analyzing PC curve (Fig. 2.22),
we need to see the role of free client and bound client in the condensate and solution. At














Figure 2.22: Monovalent SIM client partition coefficient: Non-monotonic client partition-
ing appears even though weak binding affinity of monovalent SIM clients results in slow PC
change.
enough sticky end defects in the assembly. Clients are mainly bound in gap defects but their
number are also tiny due to low monovalent client binding affinity. The number of clients
that are bound with scaffolds in solution are also small due to small binding affinity and
low free scaffold concentration. Here, the free client concentration are dominant in the PC
calculation which are equal for both the condensate and bulk. That is why PC is low (∼ 1).
In the case of small inequality of scaffold, chain length increases which opens up more sticky
end defects where clients can bind so the PC increases. If we go to very large inequality,
we will observe that PC starts to diminish. In this case, client density in the droplet turns
out to be practically steady in light of the fact that shortest possible chain length has been
reached. Therefore, they can not open more sticky end defects but scaffold concentration at
solution increases consistently.
Divalent client
We have calculated divalent SIM client PC for a fixed SIM module concentration [50µM ] and
SUMO module concentration ranging from 50µM -90µM and compared with experimental
PC7, they look close to each other [Fig. 2.23]. At equal module concentration, PC is low
likewise in monovalent client. In case of small inequality, odd N-mers opens up more sticky





















Figure 2.23: Divalent SIM client partition coefficient: The magnitude of client PC elevates
with valence (binding affinity) of clients.
to decrease even if there are a large number of sticky end defects. In this case, there are
a large volume of scaffold monomers in solution so that client not only binds with scaffold
assembly but also with monomers in solution. The non-monotonic patterns begins at an
earlier concentrations for divalent client compared to monovalent clients.
Trivalent client
We have calculated trivalent client (SIM3) partition coefficient for different scaffold concen-
trations shown in Fig. 2.24.
Experiment
Theory


















Figure 2.24: Trivalent SIM client partition coefficient: Increase in client valence not only
increases PC magnitude but also the location of PC peak.
Likewise in monovalent and divalent client, we observe the non-monotonic client parti-
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tioning behavior but the non-monotonic trend starts at an earlier concentration for trivalent
client than that for divalent and monovalent clients. We find that the maximum value of PC























































Figure 2.25: The scaffold composition that optimizes client recruitment depends on the
client valence. (a) The transfer matrix theory (lines) captures the shift in the experimental
(dots) partition coefficient peak as the client valence increases. The high affinity of trivalent
clients is more sensitive to both the appearance of defects in the droplet and the presence of
free scaffold in the bulk. Experimental data from Banani et al. (b) Concentration of unbound
SUMO modules in the dense and dilute phases. Excess scaffolds, and associated defect sites,
are initially bound in the droplet as shown by the blue curve (given by ρg times the droplet
poly-SUMO concentration). However, above 70 µM additional poly-SUMO accumulates pri-
marily in the bulk phase, which has a defect density of 10cU (red). The scaling factor applied
to the droplet curve is approximately equal to the ∼ 0.01 volume fraction of the droplets.
Therefore, these curves approximately represent the number of defects sites in each phase.
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If we analyze these three client PCs together, the most striking feature of the PC is the
non-monotonic dependence on the poly-SUMO concentration (Fig. 2.25a). This can now be
understood as follows. Small excesses of poly-SUMO scaffold are readily incorporated in the
droplet, which increases the PC by providing more sites for SIM clients to bind. However, as
previously discussed, the 1D filaments are limited in their ability to accommodate unequal
stoichiometry. As the filament ends become saturated with the abundant scaffold species,
excess scaffold monomers are forced to accumulate in the dilute phase (Fig. 2.16). At
SUMO concentrations above 75 µM the number of unpaired SUMO modules in the dilute
phase exceeds those in the dense phase (Fig. 2.25b). These free scaffolds compete for clients,
which increases client concentration in the dilute phase and lowers the PC.
The client binding response is sensitive to the valence and binding affinity of the clients.
Increasing the client valence increases the maximum value of the PC and shifts the peak
toward equal scaffold stoichiometry. The increased affinity of clients through higher valence
allows them to bind more readily to the sticky ends that appear with a small excess of
complementary scaffold. However, the larger valence of these clients means that there is
comparatively lower configuration entropy when binding to small defects. Therefore, when
free scaffolds appear in the dilute phase, the favorable entropy provided by 10 consecutive
binding sites overwhelms gap binding. Conversely, low valence clients have lower affinity,
requiring a higher defect density for appreciable recruitment. But, they do not feel a con-
finement entropy in small defects, so they are sensitive only to the total number of available
binding sites in the two phases (Fig. 2.25).
2.3.5 Network structure can provide binding specificity.
Up until this point, we have studied the behavior of clients partitioning into the droplets
for different valence clients having their fixed binding affinities. In this section, we have
considered variable client binding affinity to study how the scaffold network acts with differ-
ent valence clients having variable binding affinities. Not surprisingly, increasing the client’s















































































Figure 2.26: Increasing the client module binding affinity enhances client recruitment with
minimal effect on the location of the peak. This provides separate mechanisms to tune the
location and magnitude of client recruitment. (a) Monovalent SIM and (b) Trivalent SIM
at different module binding affinities. The different effects of client valence and affinity on
the PC curve allow the network to switch between the recruitment of different clients. (c)
With tuned client affinities, it is possible for the network to selectively recruit either the
monovalent or trivalent client in different regimes of parameter space.
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shows PC curves for a monovalent and trivalent client where the binding affinities have been
tuned to have similar peak recruitment. However, because the peaks in the PC curves occur
at different scaffold stoichiometries, the network will predominantly recruit either one client
or the other at different scaffold ratios. Therefore, the zipper microstructure of the droplet
provides independent mechanisms to tune the magnitude (via the affinity) and concentration
(via the valence) of the maximial PC. These orthogonal methods of tuning client recruitment
provide a mechanism by which the structure of the network influences the recruitment of
clients, and thus function of the droplets. This means that, despite the liquid characteristics
of the condensate, there is enough structure to specifically select between two closely related
clients. This is because the zipper structure produces correlations in the location of available
binding sites that biases the ensemble of binding states for multivalent clients. These struc-
tural correlations are not captured by random network models or the original mass action
model of Banani et al.7
2.4 Discussion
Interactions stabilizing liquid states impart functionally relevant condensate prop-
erties.
Comparing these results to the recently determined microstructure of SPOP/DAXX conden-
sates8, an interesting trend emerges. Both the SUMO/SIM and SPOP/DAXX systems can
be described as sticker and spacer motifs42;43, yet the underlying networks have very different
connectivity (Fig. 2.27). Despite the superficial differences, both systems assemble in a hier-
archical manner; strong interactions form molecular complexes and weaker interactions drive
the condensation of the complexes. In the SPOP/DAXX system, strong SPOP-DAXX in-
teractions result in the formation of brush-like assemblies that condense into a liquid phase
via weaker DAXX-DAXX interactions. However, at higher SPOP-DAXX ratios, DAXX
crosslinks SPOP into rigid bundles that associate into a gel state. These distinct states al-
low the scaffold stoichiometry to serve as a kinetic switch between fluid and arrested states8.




Excess SPOP: kinetically arrested gel
Equal stoichiometry: 
poor client recruitment
Small poly-SUMO excess: 
strong client recruitment
Large poly-SUMO excess: 
weak client recruitment
Excess DAXX: fluid droplets
Droplet
Bulk
Figure 2.27: The microscopic connectivity of biomolecule condensates imparts specific
properties. While both poly-SUMO/poly-SIM and SPOP/DAXX condensates form by the
association of multivalent molecules, the assemblies have very different properties. Poly-
SUMO/poly-SIM condensates are composed of linear filaments that provide a client binding
response that is sensitive to the scaffold stoichiometry. SPOP/DAXX assemblies contain a
“kinetic switch” that allows the system to convert between gel states with arrested dynam-
ics and fluid droplets. Here the black lines represent bivalent DAXX molecules, while the
rectangles represent polymerized SPOP rods. Adapted with permission from Schmit et al.
Copyright 2020 by the American Chemical Society.
the strong zipper formation and the weaker network crosslinks, with the presence or lack
of cooperative binding providing the two different energy scales44;45. Also, the filamentous
structure, which is favored by a spacer that is much shorter than the mean intermolecular
spacing, allows for a sensitive control over client recruitment. In both systems the assemblies
are disordered at the length scales of both the strong and weak interactions. However, the
hierarchy gives structure to the fluid in a way that provides functional properties.
We conclude that even within a conserved sticker and spacer framework, differences in
the scaffold valence, linker length, rigidity etc. can result in networks with widely different
properties. It is inevitable that evolution will exploit these differences to optimize each
condensate for its specific biological function. This inspires the question of how to identify
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functionally relevant structure within networks that are visually disordered. Here we have
shown that theoretical modeling is a powerful tool for this task because parameters like Ntot





assembly and RNA folding process in
nucleolus
3.1 Introduction
Nucleus, also called the control center of the cell, regulates cell function. The Nucleus
contains the genome, controls the gene expression and performs several functions which are
organized into sub-compartments.
There are various membraneless organelles inside the nucleoplasm46–55, including the
nucleolus, nuclear speckles, paraspeckles, PML body, cajal body etc. They are formed
through condensation (liquid-liquid phase separation) of molecules into liquid droplets56–58.
Membraneless organelles play a vital role in cellular process such DNA transcription, RNA
processing, protein synthesis etc59. The cell may use these organelles to sequester harmful
components, to store useful biomolecules, to amplify signal pathway, and to concentrate
biomolecules to accelerate the chemical reaction59–66.
There are several condensates in nucleoplasm among which nucleolus is the biggest.
Nucleolus is the site of rDNA transcription, rRNA processing and modification, and pre-
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ribosomal assembly16–18. It contains DNA, RNA and proteins19. The nucleolus has three
distinct sub-compartments14;17;18;46;67 (Fig. 3.1a). The peripheral layer, the Granular com-
ponent (GC), surrounds the Dense Fibrillar component (DFC) and the Fibrillar center (FC).
Different sets of biomolecules inside the nucleus undergo liquid-liquid phase separation into
droplets. These droplets of distinct nucleolar proteins have different biophysical properties.
In particular, the droplet surface tension is a property that can control the spatial organi-
zation of droplets. When two droplets of different surface tension coalesce, the high surface
tension phase embeds within the low surface tension phase. This behaviour is responsible for
the multilayered structure of the nucleolus14. The transcription of rDNA to rRNA happens
at the boundary between FC and DFC region68;69. The processing of rRNA and their cova-
lent modifications occurs at DFC region. The rRNA folding and pre-ribosomal assembly of
ribosomal proteins and rRNA occur in the GC region17;19;70. The nucleolus contains many
chaperones and proteins which are imported from the cytoplasm. The ribosomal subunits
are then exported to cytoplasm for ribosome biogenesis. These mutual exchanges occur
continuously between the nucleolus and the cytoplasm.
There are several proteins in granular component of nucleolus but two primary proteins
that have important role in cellular processes are Nucleoplasmin1 (NPM1)46;71 and surfeit
locus protein 6 (SURF6)72. NPM1 (nucleophosmin) is an essential protein for GC assem-
bly73;74 and acts as a chaperone for rRNA folding. It has several different roles in biological
processes such as DNA repair, chromatin remodeling, embryogenesis75;76 etc. A schematic
diagram for NPM1 is shown in Fig. 3.1c. NPM1 has three domains; two folded domains
(oligomerization domain: OD and RNA binding domain: RBD domain) are separated by a
disorder linker (DL)46. The N-terminal oligomerization domain is responsible for the forma-
tion of NPM1 pentamer, which looks like a “starfish”77 (Fig. 3.1b). The core of a NPM1
pentamer is comprised of the OD and each arm ends with a RBD. The RBD region has net
positive charge through which rRNA can crosslink NPM1 pentamers. The DL resembles a
block co-polymer with alternate blocks of positive and negative charged amino acids77;78.
There are two blocks of positive amino acids (B1 and B2) and two blocks of negative amino














Figure 3.1: (a) Nucleolus has three sub-compartments. (b) Oligomerization domain drives
pentameric NPM1. (c) The block representation of NPM1.
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Surfeit locus protein 6 (SURF6) is a non-ribosomal protein and another one significant for
the ribosomal biogenesis. The N-terminal segment of SURF6 (SURF6-N) has 182 residues
and drives NPM1 to phase separate46. It has net positive charge, with two large positive
blocks separated by a small negative charge block so that we can consider SURF6-N as two
distinct positively charged blocks (Fig. 3.2).
Figure 3.2: The charge distribution of SURF6-N shows mostly positively charged residues
with few negatively charged residues. This charge distribution suggests that we can model it
as a pair of positively charged blocks.
In this chapter, we discuss the GC assembly process and RNA folding process in two
different sections.
3.2 Granular component assembly in nucleolus
In vitro experiments have shown that NPM1 undergoes phase separation due to at least
three different types of interactions.
1) SURF6-N, a positively charged protein interacts with the negative charge of disordered
region of NPM1 molecules46;67;79.
2) rRNA crosslinks pentameric NPM1 through the RBD regions of NPM180.
3) Crowding agents allow NPM1 arms to expand and form intermolecular interaction between
positively charged blocks and negatively charged blocks of two distinct NPM1 pentamers46;67.
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3.2.1 Tails of NPM1 pentamer collapse due to interaction between
charged blocks
The disordered tails of NPM1 consists of alternating blocks of positive and negative charges.
This results in an electrostatic force between alternate blocks which causes contraction
(shown in Fig 3.3 A). In the absence of salt, the electrostatic force between alternating
charge blocks causes them to contract whereas the high salt screens the attractive force
so that they tend to extend46. Here, we discuss the free energy of collapse between the
alternating blocks.
First, consider the A2 negative charge block and B2 positively charged block (see Fig. 3.1C).
The A2 negative charge block has a very high linear charge density (26 negatively charged
residue out 28 amino acids) which favors an extended state whereas the B2 positive charge
block has a low linear charge density which allows it to adopt random coil states (Fig 3.3B).
We have modeled these blocks such that
(i) There are almost no neutral molecules between negatively charged amino acids in A2
block (Fig 3.3 B).
(ii) There are on an average four neutral amino acid between positively charged amino acids
in B2 block (Fig 3.3 B).
(iii) Consider a pair of positive and negative charge binding as shown in Fig 3.3C. There
are three different possibilities for the binding of the next pair of amino acids. First, the
next positive charge could bind with the adjacent negative charge (loop1). Second, the next
positive charge may leave the adjacent negative charge unbound and could bind with third
negative charge (loop2). Third, the next positive charge and second negative charge may
remain unbound so that the next binding event occurs between the third positive charge and
third negative charge (loop3). We have neglected other possibilities of binding.
For each of these three cases, we have calculated the electrostatic attractive energy for
the bonding between negative and positive charge, electrostatic repulsive energy between
positives charges and the repulsive entropy due to constraining the polymer to form a loop.






















Figure 3.3: (A) NPM1 tail experiences electrostatic force. (B) NPM1 A2 block resembles








where lb= 0.7 nm is Bjerrum length and a is the distance between charged residues.
For attractive energy, a= 0.2 nm
For repulsive energy, a= 0.45 nm (for loop 1) and a= 0.7 nm (for loop 2 and 3)
The loop formation entropy is given by logL, where L is total number of residues in the
loop. The calculation of free energy is shown in Table 3.1.
Loop1 Loop2 Loop3
Entropy (KBT ) log 6 = 1.79 log 6 = 1.79 log 11 = 2.39
Attractive Energy (KBT ) -3.5 -3.5 -3.5
Repulsive Energy (KBT ) 1.5 1 1
Total Free Energy (KBT ) -0.2 -0.7 -0.1
Probability 28 % 47 % 25 %
Table 3.1: The free energy for each of the states shown in Fig. 3.4C representing the
interaction between adjacent charged blocks on NPM1 tail.











In loop1 and loop3, there are equal number of positive and negative charges. But loop2
has an excess unbound negative charge and the probability of loop2 is 50%. Based on these
probabilities, we expect that the total eleven positive residues in B2 block will cover around
sixteen of the negative residues in the A2 block. The total free energy of binding between the
blocks is given by: < E >= −N logQ = −17KBT . Hence, the average energy per positive
charge is ∼ −1.5KBT .
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A similar calculation can be done for SURF6-N molecules interacting with the A2 block
of NPM1 shown in Table 3.2 are the energies of the loop states . The free energy of binding
between NPM1 and SURF6-N is given by: < E >= −N logQ = −21KBT and, hence, the
average energy per charge binding between NPM1 and SURF6-N is ∼ −1KBT . This value
∼ −1KBT is lower than average energy per binding ∼ −1.5KBT in NPM1 tail collapse which
is due to the fact that SURF6-N has lower charge density than the B2 positive block.
Loop1 Loop2 Loop3
Entropy (KBT ) log 10 = 2.3 log 10 = 2.3 log 19 = 2.94
Attractive Energy (KBT ) -3.5 -3.5 -3.5
Repulsive Energy (KBT ) 1.5 1 1
Total Free Energy (KBT ) 0.3 -0.2 0.44
Probability 28 % 47 % 25 %
Table 3.2: Calculation of different energies existing in each loop during NPM1 and SURF6-
N interaction.
As we discussed earlier, the eleven positive charges in B2 block will cover only sixteen of
the negatively charged residues in the A2 block. This allows the positively charged SURF6-N
to interact with the remaining ∼ 10 negative charges in the A2 block in such a way that
SURF6-N makes a bridge between tails of distinct NPM1 pentamers as shown in Fig. 3.4.
Since the charge distribution in two halves of SURF6-N is roughly symmetric, the first half
can interact with one pentamer whereas the second half interacts with the tail of distinct
pentamer. This forms the crosslinks between NPM1 that drives the phase separation.
3.2.2 NPM1 and SURF6-N drive phase separation
In our model, the NPM1 pentamers are treated as a lattice gas occupying a volume fraction




= φ log φ+ (1− φ) log (1− φ)− χφ2 (3.3)
where V0 is the volume of a NPM1 pentamer. The first two terms represent the entropy of




Figure 3.4: In vitro experiment provides the phase diagram for three different cases.
SURF6-N crosslinks NPM1 pentamer in either cases. (A) Wild type NPM1 (B) NPM1 with
out RBD region (C) NPM1 with out both RBD region and B2 block.




where Fdense = − logQdense = − log (1 + csurfe−E2) and Fdilute = − logQdilute = − log (1 + csurfe−E1)








where z = 5 is the co-ordination number of NPM1 pentamer, the log term describes the free
energy of pair of NPM1 arms. In the soluble state (denominator of log term) the arms are
independent, so they can be unbound or bind to a single SURF6-N molecule with energy E1.
In the aggregated state (numerator of log term) the arms can be unbound or a SURF6-N
50
binds with two arms of distinct pentamer with energy E2. Now Eq. 3.3 becomes,
F ∗ V0
V







Now, we need to find the monomer concentration of SURF6-N necessary to drive the





= 0 (This is a required condition for phase separation). On solving, we get















Using Mathematica we can numerically solve the double tangent construction for phase
separation, which gives the dilute phase and dense phase NPM1 concentration. The free
energy of phase separated system has two minima or we can draw a common tangent line
which touches two point on free energy curves. The corresponding concentrations for two
minima or at which common tangent line touches the free energy curve give the dilute and
dense phase concentration. These concentrations depend on E1 (binding interaction between
a NPM1 arm and a SURF6-N in solution state), E2 (binding interaction due to a SURF6-N
crosslinking two arms of distinct NPM1 in condensed state).
Here we would like to hightlight that we are splitting the electrostatic interaction into
two parts: (a) Short range force for NPM1 tail collapse (Table 3.1) and NPM1-SURF6-N
interaction (Table 3.2) (b) Long range Debye-Huckel potential for repulsive force between
unbound negative charges in NPM1 arms.
The electrostatic interaction energy is very complicated for disordered polymers like this.
We start by making the simplest possible approximation in which the polymers are treated








where q1 and q2 are the two charges, lb is the Bjerrum length, κ is the screening parameter,
a is the radius of the charge, and r is the distance between the charges. We will neglect the
screening term for the moments (valid if r = a). The screening length at salt concentration
Csalt = 150mM is given by
κ =
√
2 ∗NA ∗ q1 ∗ q2 ∗ Csalt
εrε0KBT
' 1.25 ∗ 109nm−1
where NA is Avogadro’s number, KB is the Boltzmann constant, εr is dielectric constant, ε0
is permittivity of vaccum. Here, we have considered three NPM1 variants studied by46.
(a) Full NPM1 (WT):
In the WT case, there is only enough unbound negative charge on NPM1 to bind one
half of SURF6-N due to the interaction between the B2 region and the A2 region. In the
condensed phase, the other half of SURF6-N can also find an adjacent NPM1 tail (Fig. 3.4A).
Using Table 3.1, Table 3.2, and Eq. 3.7, we get E1 = −10KBT , E2 = −15KBT .
b) NPM1 without RBD domain:
This case is similar to case first except we do not have the RBD region (Fig. 3.4B) so
that the net negative charge in the NPM1 tail increases which causes an increase in the
repulsive energy. Hence, using Table 3.1, Table 3.2, and Eq. 3.7 we get, E1 = −10KBT ,
E2 = −14.5KBT .
c) NPM1 without RBD domain and B2 positive block:
In this case, the electrostatic attraction exist SURF6-N and the A2 negative block of
NPM1 tail in solution state while in the condensed state, the SURF6N interacts with A2
block of two distinct NPM1 arms (Fig. 3.4C). Hence, using Table 3.1, Table 3.2, and Eq. 3.7
we get, E1 = −17KBT , E2 = −21KBT . .
Fig 3.5 shows the calculated phase separation regime which is qualitatively similar to the
experimental result46.
In case of NPM1N188 (NPM1 variant which has no RBD region and B2 block), there is no
short range polymer collapse due to absence of the positive B2 block and the RBD region.
The long range Debye-Huckel interaction between the NPM1N188 A2 block and the positively
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Figure 3.5: It compares our theoretical phase diagram with the in vitro experimental phase
diagram for three NPM1 mutants (a) NPM1WT (b) NPM1N240 and (c) NPM1N188. Green
dots and black dots represent experimental demixed and mixed phase respectively, and red
dashed line represents our theoretical phase separating lines. Qualitatively, our theoretical
predictions are in good agreement with experimental findings.
charged SURF6-N drives phase separation. We observe that the critical SURF6-N concen-
tration increases as NPM1 concentration increases. This is because there is more repulsion
between NPM1N188 due to the high charge density of the A2 block so that more positively
charged SURF6-N are needed to oppose the repulsive force. But in case of NPM1WT and
NPM1N240 (which has no RBD region), the tail collapses due to short range forces between
the A2 and B2 blocks. The tail now has low net negative charge. If we increase NPM1 con-
centration, NPM1 are easily accessible and hence, small numbers of SURF6-N are sufficient
to drive phase separation but for very high NPM1 concentration (not shown in figure), if
we increase NPM1 concentration more SURF6-N are required in relative proportion to drive
the phase separation. Qualitatively, Phase separating lines for NPM1WT and NPM1N240 are
similar but there is a quantitative difference due to the fact that NPM1N240 has no RBD
domain (i.e., it has more negative charge than WT).
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3.3 NPM1 protein acts as a chaperone in the rRNA
folding process
3.3.1 Introduction
It is thought that the phase separated environment of the nucleolus facilitates the maturation
of ribosome46. Ribosomes are responsible for reading encoded mRNA to synthesize proteins
from amino acid carried by tRNA20. Newly synthesized proteins are a random coil of amino
acids which need to fold into a stable 3D structure.
Many proteins do not fold themselves. Sometimes, they exist in misfolded state or non-
native form81. They may lead to pathological aggregates or may be degraded due to inter-
action with proteases. In many cases, even native proteins become denatured as a result
of cellular stresses81;82. Proteins might need assistance from other proteins to stop fur-
ther degradation83 or the formation of pathological aggregates of unfolded, misfolded and
non-native forms82. Those proteins that facilitate correct protein folding are called chaper-
ones84;85[Fig. 3.6]. Chaperone can break apart aggregates, stop the denaturation of native
forms by stress, and aid the formation of native structure from unfolded, misfolded, and non
-native forms81;82;84;86. There are many chaperones inside the cell and they are necessary for
life87;88.
Similar to how protein chaperone assists protein folding, other chaperones aid RNA fold-
ing by preventing or resolving misfolding states89. RNA has two types of folding problems
(a) kinetic trapping in an alternative conformation (b) difficulty in existing the thermody-
namically preferred tertiary structure90. RNA binding proteins can help to resolve either
of RNA folding problem. Non-specifically binding proteins can acts as RNA chaperones by
helping the RNA escape kinetic trap whereas specifically binding proteins may act as RNA
chaperones by stabilizing specific tertiary structure91.
As we discussed earlier, NPM1 undergoes phase separation either due to crowding agents
or due to interactions with rRNA or positively charged proteins. These modes of interactions







Figure 3.6: The schematic diagram for chaperone represenataion. Ribosomes produce un-
folded proteins. Stress may denature the native protein into unfolded or misfolded state.
Chaperone assists unfolded and misfolded protein to get their native form. Some chaperone
prevents to occur protein aggregation and some chaperones break apart the aggregation.
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at the GC-DFC boundary, then exchanging NPM1-rRNA interactions for NPM1-SURF6-N
interactions as rRNA folds92. When rRNA misfolds it is thought that NPM1 in the nucleolus
acts as a RNA chaperone by assisting unfolding rRNA so that rRNA can search for the proper
configuration in the next attempt. In the following, we will present a model describing how
NPM1 can facilitates the folding process.
3.3.2 Methods
When rRNA folds, it forms Watson-Crick helicos that we refer to as “zipper”. We assume
that the rRNA can form many different zippers, most of which are incorrect or misfolded. The
chaperone NPM1 will help unzip these misfolded regions. We call the free energy difference
between the misfolded state and unfolded state the zipper height or zipper barrier. In order
to compare the effect of chaperone folding rRNA, we consider two cases (i) rRNA with out
chaperone: In this case we assume, rRNA unfolds itself due to thermal motion. Here, rRNA
may exist in two states (Fig. 3.7A) either the folded state or the unfolded state. (ii) rRNA
with chaperone: In this case rRNA unfolds due to both thermal motion and chaperone
assistance. Here, system msy exist in four states (Fig. 3.7B). They are, A: folded rRNA,
B: partially opened rRNA due to thermal motion, C: NPM1 interacting with a partially
unfolded rRNA, D: NPM1 interacting with fully unfolded rRNA. In this section we have
introduced three different methods in order to check the effect of chaperone (NPM1) binding
in converting between the misfolded and unfolded states.
Matrix method
In matix method, we calculate the probability of unzipping the misfolded rRNA with and
without the presence of chaperone (NPM1). In order to see in detail how matrix method
works, lets start with a general case and then, apply it to our rRNA/NPM1 case.



















Figure 3.7: (A) Misfolded rRNA unzips itself in the absence of chaperone. It has two states:
E0 represents folded state and E1 represents unfolded state. (B) NPM1 assists in unzipping
misfolded rRNA. There are four possible states: A represents folded rRNA, B represents
partially opened rRNA, C represents NPM1 (indicated by star) interacting with partially
opened rRNA, D represents NPM1 interacting with fully unfold rRNA. The orange dashed























where, kij is the rate of i → j transition. Since the probabilities are time dependent i.e.
PA(t), PB(t), PC(t)....., let us convert the partial derivatives into discrete time.
∂P
∂t
→ P (t+ ∆t)− P (t)
∆t
(3.9)
Then Eqn. 3.8 becomes,













= k∆t is the transition probability in time ∆t.
Similarly,



































Now, we want Eqn 3.10 in matrix form, which gives the change in probability after time
∆t.
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Let us consider the rRNA case, where A is our initial state and D is the final state
(Fig. 3.7B). We have assumed that once system reach D state, it remains there (zipper is
fully unfolded). Our model (Fig. 3.7) only allows transitions between adjacent states, for
example, system at state B can move to state A or state C but can not jump to state D



























The probability of each state after N steps is given by,
~P (t+N∆t) = MN ~P (t)
= U−1(UMU−1)NU ~P (t)
= U−1(D)NU ~P (t)
(3.16)
In Eq. 3.16, D = UMU−1 is a diagonal matrix where the diagonal elements λ1,λ2,λ3,λ4....,
λ’s are the eigenvalues of matix M. The largest eigenvalue is λ1 = 1 and has corresponding
eigenvectors representing the equilibrium distribution of states. We take second largest eigen
value of M which represents slowest transition, in this case from state A to D. The probability
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of transitions from initial state A to final state D is given by
P = 1− λ2
where λ2 is second largest eigen value of the matrix M.
Now lets calculate the transition probability in the two different cases shown in Fig. 3.7:
(a) System without chaperone: Consider a two state system with an energy difference
∆E (Fig. 3.7A) and the ratio of transition rates satisfies the detailed balance relationship
K−
K+





Finding the second largest eigenvalue from above matrix and subtracting from 1, we get
the probability to unzip the misfolded state will be: P = K−e
−∆E.
(b) System with chaperone: Consider a misfolded rRNA has free energy ∆E . In
Fig. 3.7B, state A represents fully misfolded rRNA, state B represents the partially opened
rRNA zipper, state C represents NPM1 interacting with a partially unfolded states and state
D represents NPM1 interacting with fully unfolded rRNA. Now, we have two questions.
(i) Does the chaperone help to increase probability of unfolding the zipper?
(ii) If chaperone helps, what is the best position of NPM1 in the zipper?
In order to answer these question we have considered all positions of NPM1 in the rRNA
zipper(Fig. 3.8).
After writing matrix elements for each position and evaluating the probability, it is ob-
served that the chaperone increases the probability of transition to the unfolded state and the
effect is maximum when chaperone binds halfway through the unfolding process (Fig. 3.8).
The ratio of maximum probability with chaperone to without chaperone is approximately
equal to the exponent of the NPM1 interaction energy, therefore, the beneficial effect in all
cases arises from lowering the energy of the unfolded state. However, the location effect
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Figure 3.8: Figure shows the probability of unfolding rRNA as the function of chaperone
position in the zipper. rRNA has the total zipper length or barrier of 10KβT . We have taken
the several different position of NPM1 in zipper length. Cartoons indicate NPM1 binding to
the early, middle, and late stage unzipping.
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cannot be captured from this single free energy argument.
Analytic method
In this section, we calculate the average time required to unfold the misfolded rRNA with
and without the presence of chaperone (NPM1).
(a) Single step model
This model is analogous to the misfolded rRNA without chaperone in which there are two
states shown in Fig 3.9 with energy difference ∆E so that the ratio of transition rate between








Figure 3.9: Two state zipper system similar to Fig. 3.7A








The average required time to unfold the rRNA zipper = e∆E/K−.
(b) Three step model
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This model represents the system with chaperone (rRNA in the presence of NPM1) as in
Fig. 3.7B. First, we calculate the general expression of average time required to reach the
final state 3 from initial inital state 0 (Fig. 3.10) and then, apply the result into the our











Figure 3.10: Three step model is a general version of a system rRNA along with presence
of chaperone NPM1 (Fig. 3.7B). Fig. 3.7B is also a three step model but the step 2 has lower
enery than the step 1.
Let us consider a three step model which has four states (0,1,2,3) and the transition rates
between states shown in Fig 3.10. We are going to calculate the average time required to
travel from initial state 0 to the final state 3. If system reaches state 3, we call it a successful
walk but if system returns again to the initial state 0, we call it failed walk. Suppose there
are N walks among which the number of successful walks is PsN and the number of failed
walks is PfN . The total elapsed time for these N walks is PsNts + PfNtf .






Psts + Pf tf
)−1 (3.18)
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Fig. 3.11 shows the ways to get the successful and failed trajectories. It is clear from
Fig. 3.11A,B that system can move any number of times between states 1 and 2 but success
or failure depends on whether it reaches to state 3 or state 0 respectively.
𝑡0 𝑡1 𝑡2 𝑃1+ 𝑃2+
𝑡0 𝑡1 𝑡2 𝑡1 𝑡2 𝑃1+ 𝑃1−𝑃1+ 𝑃2+
𝑡0 𝑡1 𝑡2 𝑡1 𝑡2 𝑡1 𝑡2 𝑃1+ 𝑃1−𝑃1+ 𝑃1−𝑃1+ 𝑃2+
(A) Successful trajectories in the three steps model
(B)  Failed trajectories in the three steps model 
𝑡0 𝑡1 𝑃0+ 𝑃0−
𝑡0 𝑡1 𝑡0𝑡1 𝑃0+𝑃0− 𝑃0+𝑃0−
Elapsed time
Elapsed time
Probability of each step
Probability of each step
Figure 3.11: The schematic representation of (A) successful trajectories and (B) failed
trajectories in three steps model. Here, the probability of transition from 0→1, 1→0, 1→2,
2→1, 2 →3 are P0+, P0−, P1+, P1−, P2+ respectively. Similarly, the average time to travel
from 0→1, 1→2 or 1→0, 2→3 or 2→1 are t0, t1, t2 respectively.
The probability of transition from 0→1, 1→0, 1→2, 2→1, 2→3 are P0+, P0−, P1+, P1−, P2+
respectively. Similarly, the average time to travel from 0→1, 1→2 or 1→0, 2→3 or 2→1 are




[(t0 + t1 + t2) + n(t1 + t2)]P1+P2+(P1−P1+)
n
=






In Eq. 3.19, the first term (t0 + t1 + t2) gives the time for shortest walk consisting of three
forward steps. The second term n(t1 + t2) accounts for additional time hopping between
states 1 and 2, n times.
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In Eq. 3.20, the first term (t0 + t1) represents the shortest failed trajectory and again, the
second term n(t1 + t2) represents additional time hopping between states 1 and 2, n times.
The total success probability is given by








where, P0+ = 1
(3.21)
In Eq. 3.21, the term P0+P1+P2+ represents the minimal set of moves 0→1→2→3 in
every trajectory while the sum accounts for the different number of hopping between states
1 and 2.
Similarly, total failure probability is,








where, P0+ = 1
(3.22)
where P0+P0− is the probability of the shortest walk 0→1→0.
Hence, total probability must be 1.
































Hence average time per successive move is given by (Eq. 3.18).
Average time per success =

















Application of three steps model to NPM1 and rRNA
Let’s apply the results of three step model to a system in which NPM1 (chaperone) interacts
with the misfolded rRNA so that energy of E2 state is lower than E1 state. In this case E0
represents a zipper of misfolded rRNA, E1 represents partially opened zipper, E2 represents
the chaperone interacting with partially opened zipper and E3 represents the unfolded rRNA
with NPM1 still attached as in Fig 3.12.
In our case, we set the downhill processes to have the same free energy, K0− = K1+ =
K2− = K−, K0+ = K0−e
−(E1−E0) = K−e
























Figure 3.12: NPM1 acts a chaperone to unfold the misfolded rRNA. State E0 represents
a zipper of misfolded rRNA, state E1 represents partially opened zipper, state E2 represents
the chaperone interacting with partially opened zipper and state E3 represents the unfolded
rRNA with NPM1 still attached.


























The probability that the system moves from E1 to E2 is given by,














Similarly, the probability that the system moves from E2 to E1 is given by,
P1− = 1− P2+ =
1
e(E1−E3) + 1
Substituting all these values in Eqn. 3.25, we get the result as,
Average time per success = t0A+ t2(1 +B + C) (3.26)
where, A = (2 + eE3−E1), B = 2e
E1−E3+1
2(eE1−E3+1)
and C = (1
2
eE1−E3 + 1)












Figure 3.13: Figure shows the total average time taken to unfold rRNA zipper as the
function of chaperone position in the zipper. rRNA has the total zipper length of 10KBT .
Chaperone lowers the total time about by eEh(Eh= NPM1 interaction energy). We have
assumed that E0 = −10KBT,E1 − E2 = Eh = 3KBT , E3 = E
′
3 − E2 = −Eh.
Eq. 3.26 is plotted in Fig. 3.13. It is seen that the average time per successful trajectory
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is lower in the presence of chaperone (Fig. 3.13),i.e., the chaperone helps to lower the barrier.
We observe the minimum time occurs when the chaperone binds at the middle of the zipper.
The ratio of minimum time with out chaperone to with chaperone is approximately equal to
the exponent of the NPM1 interaction energy.
This calculation for the unzipping time is consistent with the matrix calculation of the
transition probability. In both cases the enhancement due to the chaperone is approximately
equal to the exponent of the NPM1 interaction energy. These two methods confirm the








Figure 3.14: Random walk in one dimension
We have attempted to understand how chaperone (NPM1) assists the unfolding of mis-
folded rRNA using a simple random walk. The total number of base pairs bound in the
misfolded rRNA zipper is considered as the total distance (grid) to travel by random walk.
Consider each base pair in the zipper as a grid, unfolding the zipper is a random walk that
70
ends on the right side and folding the zipper means a random walk that ends on the left side
as shown in the Fig. 3.14.
In an unbiased random walk, the probabilities to move right (unzip an unit) and to
move left (zip an unit) are equal (i.e. Pzip = Punzip = 1/2.) but in a biased random walk,
the probability of zipping an unit of zipper is larger than that of unzipping, for example,
Pzip = 4/5 & Punzip = 1/5. In each time step, random walk goes to either the left (zip) or the
right (unzip). We have accounted the average (average of 10 repeats) total time step spent
to unzip barrier (zipper) of different length in both types of random walk which is shown in
Table 3.3.








Table 3.3: We calculate the total time steps taken to unzip the zipper barrier as the function
of zipper length in both unbiased and biased random walk.
It is observed fron Table 3.3 that total time steps taken is proportional to square of zipper
length for an unbiased random walk93.
In this method, we have assumed that the presence of a chaperone breaks a longer zipper
into the two smaller pieces. If the chaperone breaks a longer zipper into two smaller zippers,
total time steps taken to unzip the whole barrier is the sum of total time steps taken to
unzip these two smaller barriers. Now we are going to figure out that which one is easier to
unzip either a full zipper or the two smaller zipper of same total length. From Table 3.3, it
is seen that for both biased and unbiased random walk,
(1) The total time steps to fully unzip single barrier is greater than the sum of total time
steps taken to unzip two smaller barriers of same total length.
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(2) The total time steps to unzip two smaller zippers of equal length is always smaller than










where, L= total length of zipper, N=1,2...L
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time steps to unzip two small barrier of unequal length.
Let us compare this model with our system of misfolded rRNA in the presence of chap-
erone molecules (NPM1). The binding of NPM1 at any position of misfolded rRNA zipper
splits a zipper into two smaller zippers. We have a result that total time steps to unzip two
smaller zipper is always smaller than that to unzip a single zipper of same total length, i.e.,
NPM1 lowers the zipper barrier. Also, we have an another result that total time steps to
unzip two equal zipper is always smaller than that to unzip two unequal zipper of same total
length, i.e., the middle of the rRNA zipper is the best placement for the chaperone NPM1
to be most effective.
Hence, all three methods indicate that the chaperone lowers the barrier height and the
middle of zipper is the most effective chaperone position to lower the barrier.
3.4 Discussion
Nucleolus is very important cellular bodies for the existence of life. It involves in major
cellular processes such as DNA transcription, rRNA processing and modification, ribosome
biogenesis etc. We have applied our modeling technique to the nucleolus to determine its
internal structure and learn how this contribution to function. It has been observed from
our study that preribosomal subunit construction is the result of phase separation of nu-
cleoplasmin (NPM1) molecules due to electrostatic interaction with SURF6-N protein. The
interaction between NPM1 and SURF6-N not only drives phase separation but also detaches
the rRNA and NPM1 interaction as a result rRNA folds. NPM1 also acts as chaperone
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moleculecule to unzip the misfolded rRNA and the middle of the zipper is the most effective
position of the chaperone to unfold the rRNA.
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Chapter 4
The prediction of antibody viscosity
from dilute solution measurements
4.1 Introduction
Antibodies are method of treatment of many diseases21;22. It can take several hours to deliver
a therapeutic dose of antibodies to a patience if prepared at low concentration. On the other
hand, high concentration solutions can be administered in a single injection, but may have
a high viscosity that creates problems in production and subcutaneous delivery27;28;94–103.
Unfortunately, the viscosity issue only shows up late in the development pipeline. There
are not adequate strategies and guidelines to test antibody viscosity in early development so
that Pharmaceutical companies can focus on low viscosity candidate molecules or optimize
possible candidates for lower viscosity. A better approach would be to predict viscosity from
dilute solution experiments104–106. Since viscosity is a many body problem whereas the dilute
solution measurements only reveal two body effects, we need a hypothesis that connects low
concentration measurements to viscosity.
Antibodies have sharp rise in viscosity at low volume fraction compared to colloids. The
high viscosity of antibody when compared with rigid body28 is not only caused by excluded






Figure 4.1: Schematic represenation of antibody
of long, flexible polymers. It has been observed from experiments that antibody possesses
mainly two type of self-association25;26;109;110 (a) binding between antigen domains (Fab−Fab
interaction, which we call Head-Head, HH binding). (b) binding between the antigen domain
and the constant domain (Fab − Fc interaction, also called Head-Tail, HT binding). Both of
these result in elongated complexes. These extended but flexible complexes entangle with
each other resulting the sharp rise in solution viscosity. To address impact of inter-molecular
interaction, we have introduced an entanglement model25;26 to predict antibody viscosity.
The entanglement model provides the connection between two-body effects (binding affinity
of molecules) and many-body effects (solution viscosity). In this chapter, we clarify how this
model enables the prediction of antibody viscosity from low concentration measurements.
There have been previous attempts to predict viscosity in the early stage of antibody
development but they do not yet have satisfactory reliability. Dilute solution measurements
such as ACSINS and DLS (we have explained about ACSINS and DLS in method section)
are one promising approach. Our entanglement model has revealed some limitations in
these dilute solution measurements and provided insights into how they can be refined. One
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limitation is that some experiments are not sensitive to certain interactions, for instance,
ACSINS experiment can not detect HT interactions, only HH binding. Other limitations are
that dilute solution experiments can not detect any many body effects or identify molecules
prone to forming branched complexes.
The correlation between dilute solution measurements has helped us to identify and filter
outliers to make these experiments more reliable in predicting viscosity. Our entanglement
model acts as a bridge between dilute solution experiments and viscosity so that we can




Figure 4.2: Different types of antibody binding (a) Head-Head (HH) binding (b) Head-Tail
(HT) binding
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Affinity parameter gives the distribution of complex sizes.
Here, I have summarized previous work in our group to determine the size of antibody
complexes25;26.
There are mainly two formss of association between antibody molecules: HH and HT
binding.
(a) Head-Head (HH) binding: Head-Head (HH) binding is the binding between antigen
binding domains of antibody molecules, as shown in Fig. 4.2A. The equilibrium constant for





where C2 is the dimer concentration and C is monomer concentration.





Since the same interaction site is responsible for the addition of each molecules, K is
same each molecular addition. The grand partition function of the system is the sum of the
concentration of monomers and all longer complexes.
Q = C +KC2 +K2C3 +K3C4 + .....
= C(1 +KC +K2C2 +K3C3 + ....)
(4.3)






The average size of complexes is given by





1 + 4KC − 1
(4.5)
(b) Head-Tail (HT) binding: Head-Tail binding is the binding between antigen binding
domain and the constant domains of an antibody. While writing partition function, we have
to include the fact that HT binding could form multiple distinguishable complexes from the
same number of monomers. The calculation accounting for this is given by Ramallo et al25.




1 + 4SC + S2C2 − (1 + SC)
√
1 + 6SC + S2C2
(4.6)
where S is equilibrium constant for HT binding.
It is clearly seen from Eqs. 4.5 and 4.6 that the equilibrium constant or binding affinity
parameter controls the size of complexes.
Reptation gives dynamical properties (kinetics)
Antibody complexes can be modeled as a polymer. At certain concentration of polymer,
the random coil volume of polymer covers the whole volume of solution and above this
concentration, the polymers are entangled. This threshold concentration is called the overlap
concentration. Above the overlap concentration, entangled antibodies can be treated as a
semidilute polymer solution26. In semidilute regime, the viscosity is proportional to the
product of the elastic modulus G and the longest relaxation time τ 111.
n ∝ Gτ (4.7)
The movement of an entangled polymer in semi-dilute regime looks like the motion of a
polymer in a tube111. Encircling and entwining polymer molecules form such a virtual tube.
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Now, The diffusion path of polymer within the tube resembles as a creeping snake112. The
term reptation explains the diffusion path in an entangled polymer.




















where ns is solvent viscosity, ν ∼ 35 is flory exponent and C
∗ ∼ L1−3νb−3 is the overlap
concentration111.
This reptation model is valid if the polymer length is much larger than the monomer
size. However, this model provides reasonable agreement with experiments, even though the
average length of complexes, between 3 to 10 molecules, is too short to satisfy the criteria26.









1 + 4KC − 1
)3 (4.11)
where A is a proportionality constant with the value 5.4 ∗ 10−8cp(mg
ml
)3.75 obtained by fitting
this model to experiments26. It is seen that the viscosity of antibodies in the semidilute
regime not only depends on concentration but also depends on the binding affinity.
In conclusion, our entanglement model connects the binding affinity of molecules with




AMGEN provided us with a data set containing viscosity, ACSINS measurements and DLS
measurements of sixty three antibodies. We used the ACSINS diffusion value, ACSINS
plasmon shift, DLS kD values, the viscosity around 70 mg/ml and viscosity around 150
mg/ml in our analysis. In this section, we briefly discuss about the experiments and their
measurements.
ACSINS Method
ACSINS (Affinity-Capture Self Interaction Nanoparticle Spectroscopy) is a new approach
to measure monoclonal antibodies (mABs) self-association101;104–106;114;115. In this method,
gold nanoparticles are coated with capture antibodies and non-capture antibodies (Fig. 4.3).
Capture antibodies bind human mABs to be tested from dilute solution whereas non-capture
antibodies do not interact with the test antibodies but they prevent test mABs from inter-
acting directly with the gold nanoparticle. These coated nanoparticles create a crowded envi-
ronment for low concentration mABs to self-associate through multi-body inter-molecular in-
teraction. Antibody self-associations can be measured in two ways; the apparent diffusion of
nano-particles and the plasmon wavelength λp which is the maximum absorbance wavelength
in the visible spectrum. Change in the plasmon wavelength upon self-association of antibod-
ies reflects the strength of self-association i.e. the large change in plasmon wavelength(∆λp)
indicates stronger self-interaction between mAbs. The ratio of capture to non-capture anti-
body also controls the association of nanoparticles by controlling the density of test mABS.
(a) ACSINS amplifies weak interaction.
ACSINS not only creates the crowded environment for human mAbs to self-associate but
also amplifies weak interactions between mAbs. This amplification depends on the ratio of
capture to non-capture antibody which are used to coat the gold nano-particle. The higher
the ratio, more test antibodies captured on a gold nanoparticle and hence, the more weak
interactions between nanoparticles (Fig 4.3). We can tune the strength of interactions be-




















Figure 4.3: The schematic diagram of ACSINS method (a) gold nanoparticle coated with
only non-captured antibody doesnot assist further assembly. (b) the ratio of capture to non-
capture antibody control the self-association of antibody (c) gold nanoparticle coated only
with capture antibody amplifies weak interaction to a large extent (d) large shift in plasmon
wavelength is the indicator of strong self association.
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(b) ACSINS does not see HT intercations.
Since the capture antibody is designated to bind the tail of human mAbs, ACSINS allows
the self-interaction of human mAbs only through head-head interaction i.e. ACSINS method
is blind to HT interactions (Fig 4.3).
(c) ACSINS diffusion (Nanoparticle diffusion) is not sensitive to strong interac-
tions.
It has been observed that ACSINS diffusion (Nano-particle diffusion) quickly decays with
binding affinity, but is not sensitive to strong interaction (Fig. 4.4A). If capture antibody
density is high, it amplifies the weak interaction so that it forms the longer complexes even

























HH interaction parameter (viscous k)
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Figure 4.4: The ratio of capture to non-capture antibody in coated gold nano-particle de-
termines ACSINS sensitivity range. (a) Strong interaction with high capture antibody may
result fractal form (b) Size of fractal structure is almost same for large assembly
The size of fractal structure is given by R ∝ N
1
df , where df is fractal dimension and N is








For high binding affinity (strong interaction), each cluster has large number of nanoparti-
cles. It is seen from Fig. 4.4B that cluster size changes significantly even for small growth but
for large cluster, R varies weakly with N so that the diffusion coefficient is sensitive to small
clusters (weak interaction) but it is almost constant for large cluster (strong interaction).
(d) ACSINS lambda shift is not sensitive to weak interaction.
In ACSINS, antibody self association can also be assessed by the change in plasmon wave-
length. Plasmon shift depends on the volume of the nanoparticle cluster. As shown in
Fig. 4.5A, the volume for smaller clusters is low where as that volume is high for larger
complexes. Therefore weak interactions that form small sized complexes (Fig. 4.5B) have
a small plasmon shift. As a result weak interaction are not distinguishable because the in-
terior volumes of small sized clusters are almost same. But from Fig. 4.5B, it is seen that
nano-particle plasmon is sensitive to large clusters because the volume increases significantly
in large size clusters.
Since both ACSINS and DLS are not sensitive to strong interaction, plasmon shift could
be the most appropriate way to measure strong particle affinity but there are still some
outliners for strong interaction (Fig. 4.5B). This could be because the strong interactions are
prone to kinetic traping so that strongly interacting systems are sensitive to waiting time.
Dynamic light scattering (DLS)
DLS is a light scattering experiment in which the particles are illuminated by laser light and
scattered light is studied by a detector. The information imprinted in the scattered light
can be used to determine the particle size and mutual diffusion coefficient27;104;116–118. The
mutual diffusion coefficient (Dm) is a measure of rate of a non-equilibrium mass transfer
process.119. The plot of the mutual diffusion coefficient (Dm) as a function of antibody
concentration(C) (Eqn. 4.12) gives self diffusion coefficient (Do) as a y-intercept value and






















Figure 4.5: Plasmon shift measures the strength of mAbs self association. (a) Volume that
tends to form cluster determines the plasmon shift (b) Plasmon shift is sensitive to strong
interaction but not for weak interaction. The outliers may be the result of kinetic trapping
in the strongly interacting system.
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measurement of molecular movement or displacement due to the thermal motion.
DM = DO(1 + kDC) (4.12)
Eq. 4.12 shows the first order concentration dependence of the diffusion coefficient. The
diffusion interaction parameter (kD) is very useful to study the interaction of molecules
120.
If kD is negative, the diffusion coefficient decreases with concentration, which indicates that
the molecules are attractive. Positive kD values are indicative of repulsive inter-molecular
interactions for which diffusion coefficient increases with concentration. The value of kD
depends on the solution environment such as PH, ionic strength.
Zoom
(A) (B)
Figure 4.6: This graphs shows free particle diffusion for different binding affinity range.
Binding affinity (K) represents viscous behavior of of molecules. (A) DLS is not sensitive to
strong interaction (B) Zoom in of free particle diffusion only for low viscous molecules. Free
particle diffusion decays linearly with binding affinities of low viscous molecules.
Fig. 4.6A shows that strong interaction are only outliers, i.e., DLS sees HT interaction.
Therefore, DLS addresses the inability of ACSINS to detect HT interaction but it also has
difficulty with strongly interacting molecules.
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4.2.3 Proposed method
In previous section we have discussed some drawbacks in dilute solution measurements so
that they are not successful to predict about all molecules. The following are the proposed




Figure 4.7: Nono-particle diffusion quickly decays with binding affinity. Plot (a) and (b)
are same but are plotted in different affinity range.(a) Nano-particle diffusion is not sensi-
tive to strong binder (Generally, molecules with binding affinity larger than 0.01 are strong
binders (SB).) (b) Nano-particle diffusion is blind to HT interaction. Three molecules at
the center of right side figure which have large ACSINS diffusion but binding affinity is not
low. This discrepancy between the viscosity and the ACSINS diffusion can be explained if
the nanoparticle capture antibodies block the interaction that drives viscosity. Therefore, we
predict these are HT outliers.
(a) Reduce capture antibody density: As we discuss earlier, ACSINS diffusion is not
sensitive to strong interaction (flat region in Fig. 4.7A) but if we reduce the capture antibody
density, we can reduce the number of antibody-antibody interaction between nanoparticles.
This can shift the ACSINS diffusion back into the sensitive range. In case of reduced capture
antibody density weak interaction may not form longer complexes (flat region in Fig. 4.8)
































too weak to bind
bind too strong to be sensitive
Figure 4.8: Adjusting the density of capture antibodies whether ACSINS is sensitive to
strong or weak binding.
(b) Filter HT molecules: ACSINS does not see HT interaction (Fig. 4.7B) but DLS does.
If we plot ACSINS diffusion (ACSINS DiffC) and DLS diffusion (kD) together, we expect
they will show a linear relationship as long as the interaction sites are accessible in both
experiments. Therefore, we predict the outliers in the plot are HT molecules. This provides
a method to filter these molecules in our prediction algorithm. Alternatively, if we choose
two different types capture antibody which could bind either the head or tail of the test
mAbs, we can separately test HT interactions by ACSINS (Fig. 4.9).
(c) Avoid kinetic trap: The plasmon shift is sensitive to strong interaction and is a promis-
ing approach to assess the strong interactions but there are still some outliers. These outliers
may be the result of kinetic trapping. Kinetic trapping, an outcome in which proteins are re-
strained to non-equilibrium conformations because of an energy barrier that cannot be quick
overcome with out external force or extended timescales. The strong interaction regime
where the plasmon shift is sensitive is particularly prone to kinetic trap. The equilibrium
time for strong interactions is long due to the time required for bonds to break and re-form.
Therefore, the waiting time (time between sample preparation and measurement) may effect
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Standard AC-SINS Proposed solution
Figure 4.9: Inverted ACSINS mechanism could solve HT problem.
the experimental result. To avoid being kinetically trapped, we can reduce the strength of
weak interaction by reducing the capture antibody density (Fig. 4.8).
(d) Find best fit line: Based on the sample data set, we can predict the viscosity from
ACSINS diffusion values or DLS kD values which is described in the following steps. (i)
Sample data provides the viscosity at two different concentration points. Using our entan-
glement model, we can determine the binding affinity from these two viscosity values for
each molecules. (ii) Then, we plot “Nano-particle diffusion vs binding affinity” and “Free
particle diffusion vs binding affinity” for all sample molecules. Next, we find the best fit line.
(iii) Using the best fit line, we can estimate the binding affinity for given ACSINS and DLS
value for the test set molecules. (iv) This best fit line can be used to calculate the viscosity
of new molecules using the entanglement theory.
The method described in (a)-(d) is shown as the flow chart in Fig. 4.10.
4.3 Results
We have sample data of about 60 molecules, which provides ACSINS diffusion, DLS kD
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Figure 4.10: Flow chart of the proposed method for predicting antibody viscosity.
two viscosity value and our entanglement model, we calculate binding affinity parameter, K,
for each molecule. Then we plot ACSINS diffusion vs binding affinity for sample data. The
following are the steps we have taken.
4.3.1 Classification of molecules
Comparing ACSINS to the viscosity, we identify four groups (Fig. 4.11): 1) HT group:
These molecules have very high ACSINS diffusion values, but also have a high viscosity.
2) Strong Binders (SB) group: These molecules have low ACSINS diffusion values and
very high binding affinity. But ACSINS diffusion is not as low as the regression line would
predict. 3) False Positive (FP) group: These molecules have both low ACSINS DiffC
values and viscous values. It is unclear what may cause this discrepancy but they do not lie
within the range of our interest because they are low viscosity molecules. 4) Trend Line





Figure 4.11: Comparision of the ACSINS diffusion and solution viscosity reveals four
groups. (A) Molecules having very high binding affinity are the Strong Binder(SB) groups.
(B) The same plot as ‘(A)’ but binding affinity range is limited. Molecules having both
diffusion and binding affinity high are classified into HT group. Similarly, molecules having
both diffusion and binding affinity low are classified into the False Positive (FP) group. Other
molecules which follow the expected trend between diffusion and viscosity are the Trend Line
(TL) group.
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4.3.2 Filtering HT molecules
If we plot nanoparticle diffusion (ACSINS DiffC) vs free particle diffusion (DLS kD), they
show an linear relationship as shown in Fig. 4.12. There are big outliers in the upper left
corner of the graph which we predict are HT binding molecules because those interactions
can not be seen by the ACSINS method.
Figure 4.12: We expect the linear relationship even though nano-particle diffusion and free
particle diffusion are two distinct diffusion parameters. The relation between two different
diffusion measurements identifies the HT outliers enclosed in a red circle.
We have proposed that these molecules can be assessed by ACSINS if we reverse the
capture orientation on half of the nanoparticles so that HT binding between mAbs is possi-
ble 4.13).
4.3.3 Finding regression line
Our entanglement model implies that the viscosity is the function of concentration and length
of complexes (η = AC3.75L3, where length L is the function of concentration and binding
affinity). We calculate binding affinity for each molecule using viscosity at two different point
concentrations. Then, we plot the ACSINS diffusion coefficient (DiffC) vs binding affinity































Viscous (k) Viscous (k)
(A) (B)
Figure 4.13: (A) ACSINS measurement does not detect HT interactions (see cartoon) so
that we see the data points scattered from the best fit line. (B) We propose inverted ACSINS
(see cartoon) to measure HT interactions and generate a best fit line for HT molecules (data
and trend line are cartoons).
The best regression equations for these two cases are as follows:
DiffC = 4 exp−K∗750 (4.13)
kD = 55−K ∗ 14000 (4.14)
From these relations we can predict the antibody binding affinity from ACSINS and
DLS measurements. Then, we can predict the concentration dependent viscosity using our
entanglement theory.
4.3.4 Testing our hypothesis in new data set
After developing the algorithm described above, AMGEN provided us with a test set of 17
molecules with ACSINS diffusion coefficient (DiffC) and DLS interaction parameter (kD).
The predicted viscosity as the function of concentration for these test data set are shown
in Fig. 4.14. The comparison of actual viscosity and viscosity predicted from ACSINS and
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DLS measurement are shown in bar plot (Fig 4.15).




















Viscosity predicted AC SINS Viscosity predicted DLS Kd Measured viscosity @ ~ 150 mg/mL
1        2         3        4        5         6        7        8         9       10      11      12      13      14      15 16      17
Figure 4.15: Dilute solution measurements looks promising to predict the antibody viscosity.
It is clearly seen from bar diagram (Fig 4.15) that our predicted viscosity matches well
with actual viscosity although there are also outliers. In cases where the ACSINS viscosity
prediction is much lower than the DLS viscosity prediction, the DLS viscosity and the actual
viscosity are in good agreement. This is the expected signature of HT binders. If the
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actual viscosity is much larger than the ACSINS viscosity prediction and the DLS viscosity
prediction, such molecules belong to the strong binder (SB) group. If we apply the sample
set observation into test set molecules, molecule 1 is an HT candidate and molecules 2, 7,
9 and 15 are possible SB candidates (Fig 4.15). The modified dilute solution experiments
suggested above can be used to test these predictions and validate our method.
4.4 Discussion
The large mass of antibody required for therapeutic doses requires high concentration that
can result in problematic viscosity in production and delivery. Predicting antibody viscosity
in the early stage of development pipeline could assist in cost reduction. The reason for sharp
rise in antibody viscosity at the required dosing is identified as similar to the entanglement
of long, flexible polymers. Recent years, there have been many efforts to predict antibody
viscosity from dilute solution measurements. Our entanglement model26 links two-body
binding affinity to the many-body viscosity. In this study we have connected dilute solution
measurements to the binding affinity of molecule in order to allow binding affinity to act as
a bridge between dilute solution measurements and viscosity. Our model has been successful
in predicting viscosity from dilute solution measurements except some outliers. We have not
only identified the outliers but also explained the physical mechanics behind these outliers
and proposed the solutions to make the dilute solution measurements more efficient. The




Conclusion and future works
5.1 Conclusion
In the concentrated biomolecules system, there is the potential for many types of inter-
molecular interactions. We have found that the structure of these systems can be described
in a hierarchical manner such that relatively strong interactions, form the molecular com-
plexes, while weak interaction drives the many body effect. In the SUMO/SIM system,
strong SUMO/SIM interactions form zipper-like network, whereas weak cross-links in defect
sites drive phase separation44;45. In human mAbs, strong interactions between domains form
the elongated complexes, whereas entanglement causes the sharp rise in viscosity. In the nu-
cleolus, strong interaction among the N-terminal domains of NPM1 drives NPM1 pentamers
whereas weak interaction (NPM1-SURF6, NPM1-rRNA) drives the phase separation and
facilitates the formation of pre-ribosomal sub units.
In chapter two, we discussed the structure-function properties in bio-molecular conden-
sates. There are large number of membrane-less organelles inside the cell which are formed
by the condensation of large number of molecules. A small number of molecules, called
“scaffolds” produce a phase separated network with liquid-like properties, and these net-
works recruit other molecules, called “clients”. We studied the synthetic system of phase
separating molecules designed by Rosen and co-workers7. There are two types of scaffolds
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(polySUMO/polySIM) and two types of clients(SUMO/SIM). Since the condensed phase a
lower density than we would expect for a random network, we propose that molecules are
aligned to form a zipper structure and these zippers have defects in the bonding structure
that allow for the subsequent formation of a network and client recruitment. Our theory pre-
dicts the non-monotonic client partitioning behavior similar to that are seen in experiments.
At equal scaffold concentrations, even N-mer complexes are more favorable than odd N-mers
in the condensates. At unequal scaffold concentrations, odd N-mers are more favorable than
even N-mers whereas at high scaffold stoichiometric mismatches, shorter odd N-mers are
more favorable and excess monomer starts to accumulates in the solution. The filamentous
structure constrains the scaffold stoichiometries and the distribution of client recruitment
sites that the network can accommodate. The filamentous micro-structure of the droplet is
sensitive to the valence and binding affinites of clients, which provides independent mech-
anisms to tune the magnitude (via the affinity) and the location (via the valence) of client
recruitment. With tuned client affinities, it is possible for the network to specifically select
between closely related clients in the different regimes of parameter space. This confirms
that even though condensate are liquid droplets, they have enough structure to bind differ-
ent valence clients and the change in body composition due to different scaffolds/proportions
which allows the system to change the functionality of the droplets.
In chapter three, we discussed the concurrent pre-ribosomal assembly and rRNA folding
process in the nucleolus. The nucleolus is the largest condensate in the nucleoplasm which
is the site of DNA transcription, rRNA pre-processing, and pre-ribosomal assembly16–18;46.
We applied our modeling techniques to the nucleolus to determine its internal structure and
understand how this structure relates to the ribosome assembly function. The outermost
layer of nucleolus is the site of pre-ribosomal assembly and rRNA folding. The primary
protein for these processes is NPM1. We modeled the interaction between the NPM1 and
positively charged protein like SURF6. Phase separation is a competition between collapses
of oppositely charged blocks and the long range repulsion. We also modeled the folding and
unfolding of rRNA in early assembly. We found that NPM1 acts as a chaperone to fully
unzip the misfolded state so that rRNA re-attempts to fold. In our model, we have developed
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(a) matrix method which accounts the probability of unzipping misfolded rRNA due to
chaperone. (b) First passage calculation (which accounts the time taken by misfolded rRNA
to fully unzip with chaperone assistance) (c) Random walk method: In this computation, we
account total number of discrete time step required to unzip the misfolded rRNA in case of
chaperone assistance). We have found that the chaperone NPM1 helps to unfold misfolded
rRNA by lowering the zipper barrier and the middle of the rRNA zipper is the best position
of chaperone to unzip the rRNA zipper.
In chapter four, we discussed the importance of dilute solution measurements to predict
antibody viscosity. The concentrated solutions required for efficient dosing possesses high
viscosity that creates problems in drug formulation and subcutaneous delivery. We present
a physics-based model to predict viscosity at early stage of development which promises to
reduce the cost of drug development. Our model assumes that interaction between antibody
variable domains results in the formation of elongated complexes and these complexes en-
tangle with each other25;26. Our entanglement model accounts for the reptation dynamics of
these complexes and shows that the viscosity not only depends on concentration, but also
on the binding affinity of molecules. Therefore, knowing the binding affinity of molecules
assists in predicting antibody viscosity as a function of concentration. We have used the
data from dilute solution measurements to predict the binding affinity of molecules. The
dilute solution experiments (ACSINS and DLS) measure the strength of self association of
molecules104. Our entanglement theory determines the binding affinity of each molecules
from measured viscosity values in sample data set. We plot the regression line between these
binding affinities and the corresponding dilute solution measurements. These regression lines
are used to predict the binding affinity of molecules from ACSINS and DLS measurements.
Our entanglement theory then predicts the viscosity from these binding affinities. Our model
enables the prediction of antibody viscosity from dilute solution measurements. We have
proposed physical mechanism for the outliers as well as experimental modification to account
for these mechanisms in the future.
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5.2 Future works
We can extend our work on SUMO/SIM droplets to study the formation of other cellular
condensates inside the cell and their structure-function relationships. In SUMO/SIM sys-
tem, the size of linker length is fixed (which is 12 amino acids) and both scaffolds have same
length (deccavalent scaffold). We can extend our work to study how variable linker length
and unequal valence scaffolds affect condensate formation and the functionality of droplets.
In the nucleolus project we observe only the phase separation due to hetero-type NPM1-
SURF6 interactions. We can extend our work to understand how homotype (NPM1-NPM1)
interactions with the aid of crowding agents, drives phase separation. Also, our three (ma-
trix, analytic, random walk) methods tells us that NPM1 chaperone lowers the zipper barrier
in misfolded rRNA. We can test the prediction of the model using a computer simulation
that more closely mimics the real system. In the antibody project, we have proposed phys-
ical mechanisms for outlier molecules in the dilute solution measurements and experiments
to test for similar molecules. Experiment testing these proposed mechanisms will allow us
to analyze more about the outliers and it will significantly contribute to better viscosity
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gus I. Lamond. The multifunctional nucleolus. Nature Reviews Molecular Cell Biology,
8:574–585, 2007.
[18] Marie-Line Dubois and Francois-Michel Boisvert. The Nucleolus: Structure and Func-
tion. Springer International Publishing, Cham, 2016. ISBN 978-3-319-38882-3. doi: 10.
1007/978-3-319-38882-3 2. URL https://doi.org/10.1007/978-3-319-38882-3_2.
[19] Carl C Correll, Jiri Bartek, and Miroslav Dundr. The nucleolus: a multiphase con-
densate balancing ribosome synthesis and translational capacity in health, aging and
ribosomopathies. Cells, 8(8):869, 2019.
[20] Albert E Dahlberg. The functional role of ribosomal rna in protein synthesis. Cell, 57
(4):525–529, 1989.
[21] Krishan Maggon. Monoclonal antibody “gold rush”. Current Medicinal Chemistry, 14
(18):1978–1987, 2007. ISSN 0929-8673/1875-533X. doi: 10.2174/092986707781368504.
URL http://www.eurekaselect.com/node/59601/article.
[22] Janice M. Reichert. Monoclonal antibodies as innovative therapeutics. Current
Pharmaceutical Biotechnology, 9(6):423–430, 2008. ISSN 1389-2010/1873-4316. doi:
10.2174/138920108786786358. URL http://www.eurekaselect.com/node/68138/
article.
[23] LH Bookbinder, A Hofer, MF Haller, ML Zepeda, G-A Keller, JE Lim, TS Edgington,
HM Shepard, JS Patton, and GI Frost. A recombinant human enzyme for enhanced
interstitial transport of therapeutics. Journal of Controlled Release, 114(2):230–241,
2006.
[24] Dheeraj S. Tomar, Sandeep Kumar, Satish K. Singh, Sumit Goswami, and Li Li.
Molecular basis of high viscosity in concentrated antibody solutions: Strategies for high
102
concentration drug product development. mAbs, 8(2):216–228, 2016. doi: 10.1080/
19420862.2015.1128606. URL https://doi.org/10.1080/19420862.2015.1128606.
PMID: 26736022.
[25] Nelson Ramallo, Subhash Paudel, and Jeremy Schmit. Cluster formation and en-
tanglement in the rheology of antibody solutions. The Journal of Physical Chem-
istry B, 123(18):3916–3923, 2019. doi: 10.1021/acs.jpcb.9b01511. URL https:
//doi.org/10.1021/acs.jpcb.9b01511. PMID: 30986054.
[26] Jeremy D. Schmit, Feng He, Shradha Mishra, Randal R. Ketchem, Christopher E.
Woods, and Bruce A. Kerwin. Entanglement model of antibody viscosity. The Journal
of Physical Chemistry B, 118(19):5044–5049, 2014. doi: 10.1021/jp500434b. URL
https://doi.org/10.1021/jp500434b. PMID: 24758234.
[27] Sandeep Yadav, Steven J. Shire, and Devendra S. Kalonia. Factors affecting the vis-
cosity in high concentration solutions of different monoclonal antibodies. Journal of
Pharmaceutical Sciences, 99(12):4812–4829, 2010. ISSN 0022-3549. doi: https://doi.
org/10.1002/jps.22190. URL https://www.sciencedirect.com/science/article/
pii/S0022354915323662.
[28] Zhenhuan Zhang and Yun Liu. Recent progresses of understanding the viscosity of
concentrated protein solutions. Current Opinion in Chemical Engineering, 16:48–55,
2017. ISSN 2211-3398. doi: https://doi.org/10.1016/j.coche.2017.04.001. URL https:
//www.sciencedirect.com/science/article/pii/S2211339816301198. Nanotech-
nology / Separation Engineering.
[29] Ming-Tzo Wei, Shana Elbaum-Garfinkle, Alex S. Holehouse, Carlos Chih-Hsiung Chen,
Marina Feric, Craig B. Arnold, Rodney D. Priestley, Rohit V. Pappu, and Clifford P.
Brangwynne. Phase behaviour of disordered proteins underlying low density and high
permeability of liquid organelles. Nature Chemistry, 9:1118–1125, 2017. ISSN 1755-
4349. doi: 10.1038/nchem.2803. URL https://doi.org/10.1038/nchem.2803.
103
[30] Peiguo Yang, Cécile Mathieu, Regina-Maria Kolaitis, Peipei Zhang, James Messing,
Ugur Yurtsever, Zemin Yang, Jinjun Wu, Yuxin Li, Qingfei Pan, and et al. G3bp1 is
a tunable switch that triggers phase separation to assemble stress granules. Cell, 181
(2):325 – 345.e28, 2020. ISSN 0092-8674. doi: https://doi.org/10.1016/j.cell.2020.03.
046. URL http://www.sciencedirect.com/science/a\left(\right)rticle/pii/
S0092867420303391.
[31] Wenmin Xing, Denise Muhlrad, Roy Parker, and Michael K. Rosen. A quantitative in-
ventory of yeast p body proteins reveals principles of compositional specificity. bioRxiv,
2018. doi: 10.1101/489658. URL https://www.biorxiv.org/content/early/2018/
12/07/489658.
[32] Lindsay B. Case, Jonathon A. Ditlev, and Michael K. Rosen. Regulation of trans-
membrane signaling by phase separation. Annual Review of Biophysics, 48(1):465–
494, 2019. doi: 10.1146/annurev-biophys-052118-115534. URL https://doi.org/
10.1146/annurev-biophys-052118-115534. PMID: 30951647.
[33] Yi-Hsuan Lin, Jianhui Song, Julie D. Forman-Kay, and Hue Sun Chan. Random-phase-
approximation theory for sequence-dependent, biologically functional liquid-liquid
phase separation of intrinsically disordered proteins. Journal of Molecular Liquids, 228:
176 – 193, 2017. ISSN 0167-7322. doi: https://doi.org/10.1016/j.molliq.2016.09.090.
URL http://www.sciencedirect.com/science/article/pii/S0167732216322449.
From simple liquids to macromolecular solutions: recent experimental and theoretical
developments. In Honor of the 70th birthday of Vojko Vlachy.
[34] Tyler S Harmon, Alex S Holehouse, Michael K Rosen, and Rohit V Pappu. Intrinsically
disordered linkers determine the interplay between phase separation and gelation in
multivalent proteins. eLife, 6:e30294, nov 2017. ISSN 2050-084X. doi: 10.7554/eLife.
30294. URL https://doi.org/10.7554/eLife.30294.
[35] Jie Wang, Jeong-Mo Choi, Alex S. Holehouse, Hyun O. Lee, Xiaojie Zhang, Marcus
Jahnel, Shovamayee Maharana, Régis Lemaitre, Andrei Pozniakovsky, David Drechsel,
104
and et al. A molecular grammar governing the driving forces for phase separation of
prion-like rna binding proteins. Cell, 174(3):688 – 699.e16, 2018. ISSN 0092-8674.
doi: https://doi.org/10.1016/j.cell.2018.06.006. URL http://www.sciencedirect.
com/science/article/pii/S0092867418307311.
[36] Alexander N. Semenov and Michael Rubinstein. Thermoreversible gelation in solutions
of associative polymers.1.statistics. Macromolecules, 31:1373–1385, 1998. ISSN 0024-
9297. doi: 10.1021/ma970616h. URL https://doi.org/10.1021/ma970616.
[37] Jeong-Mo Choi, Alex S. Holehouse, and Rohit V. Pappu. Physical principles underlying
the complex biology of intracellular phase transitions. Annual Review of Biophysics,
49(1):107–133, 2020. doi: 10.1146/annurev-biophys-121219-081629. URL https://
doi.org/10.1146/annurev-biophys-121219-081629. PMID: 32004090.
[38] B. H. Zimm and J. K. Bragg. Theory of the phase transition between helix and random
coil in polypeptide chains. The Journal of Chemical Physics, 31(2):526–535, 1959. doi:
10.1063/1.1730390. URL https://doi.org/10.1063/1.1730390.
[39] J B Pendry. Transfer matrices and conductivity in two- and three-dimensional systems.
i. formalism. Journal of Physics: Condensed Matter, 2(14):3273–3286, apr 1990. doi:
10.1088/0953-8984/2/14/012. URL https://doi.org/10.1088.
[40] Elizabeth S. Freeman Rosenzweig, Bin Xu, Luis Kuhn Cuellar, Antonio Martinez-
Sanchez, Miroslava Schaffer, Mike Strauss, Heather N. Cartwright, Pierre Ronceray,
Jürgen M. Plitzko, Friedrich Förster, and et al. The eukaryotic co2-concentrating
organelle is liquid-like and exhibits dynamic reorganization. Cell, 171(1):148 – 162.e19,
2017. ISSN 0092-8674. doi: https://doi.org/10.1016/j.cell.2017.08.008. URL http:
//www.sciencedirect.com/science/article/pii/S0092867417309339.
[41] Bin Xu, Guanhua He, Benjamin G Weiner, Pierre Ronceray, Yigal Meir, Martin C
Jonikas, and Ned S Wingreen. Rigidity enhances a magic-number effect in polymer
105
phase separation. Nat Commun, 11:1561, 2020 Mar 25 2020. ISSN 2041-1723. doi:
10.1038/s41467-020-15395-6.
[42] Melissa R Marzahn, Suresh Marada, Jihun Lee, Amanda Nourse, Sophia Kenrick,
Huaying Zhao, Gili Ben-Nissan, Regina-Maria Kolaitis, Jennifer L Peters, Stanley
Pounds, and et al. Higher-order oligomerization promotes localization of spop to liquid
nuclear speckles. The EMBO Journal, 35(12):1254–1275, 6 2016. ISSN 1460-2075. doi:
10.15252/embj.201593169. URL https://doi.org/10.15252/embj.201593169.
[43] Jill J. Bouchard, Joel H. Otero, Daniel C. Scott, Elzbieta Szulc, Erik W. Martin,
Nafiseh Sabri, Daniele Granata, Melissa R. Marzahn, Kresten Lindorff-Larsen, Xavier
Salvatella, and et al. Cancer mutations of the tumor suppressor spop disrupt the
formation of active, phase-separated compartments. Molecular Cell, 72(1):19 – 36.e8,
2018. ISSN 1097-2765. doi: https://doi.org/10.1016/j.molcel.2018.08.027. URL http:
//www.sciencedirect.com/science/article/pii/S1097276518306877.
[44] Kamal Bhandari, Michael A. Cotten, Jonggul Kim, Michael K. Rosen, and Jeremy D.
Schmit. Structure–function properties in disordered condensates. The Journal of
Physical Chemistry B, 125(1):467–476, 2021. doi: 10.1021/acs.jpcb.0c11057. URL
https://doi.org/10.1021/acs.jpcb.0c11057. PMID: 33395293.
[45] Jeremy D. Schmit, Marina Feric, and Miroslav Dundr. How hierarchical inter-
actions make membraneless organelles tick like clockwork. Trends in Biochemi-
cal Sciences, 46(7):525–534, 2021. ISSN 0968-0004. doi: https://doi.org/10.1016/
j.tibs.2020.12.011. URL https://www.sciencedirect.com/science/article/pii/
S0968000420303236.
[46] Diana M. Mitrea, Jaclyn A. Cika, Christopher B. Stanley, Amanda Nourse, Paulo L.
Onuchic, Priya R. Banerjee, Aaron H. Phillips, Cheon-Gil Park, Ashok A. Deniz, and
Richard W. Kriwacki. Self-interaction of npm1 modulates multiple mechanisms of
liquid-liquid phase separation. Nature Communications, 2018.
106
[47] Danièle Hernandez-Verdun. Assembly and disassembly of the nucleolus during the
cell cycle. Nucleus, 2(3):189–194, 2011. doi: 10.4161/nucl.2.3.16246. URL https:
//doi.org/10.4161/nucl.2.3.16246. PMID: 21818412.
[48] Asen A Hadjiolov. The nucleolus and ribosome biogenesis, volume 12. Springer Science
& Business Media, 2012.
[49] Angus I Lamond and David L Spector. Nuclear speckles: a model for nuclear organelles.
Nature reviews Molecular cell biology, 4(8):605–612, 2003.
[50] DL Spector and AI Lamond. Nuclear speckles. cold spring harb perspect biol 3:
a000646. Either first page or author must be supplied. AMBIGUOUS (137 citations),
2011.
[51] Archa H Fox and Angus I Lamond. Paraspeckles. Cold Spring Harbor perspectives in
biology, 2(7):a000687, 2010.
[52] Archa H Fox, Yun Wah Lam, Anthony KL Leung, Carol E Lyon, Jens Andersen,
Matthias Mann, and Angus I Lamond. Paraspeckles: a novel nuclear domain. Current
Biology, 12(1):13–25, 2002.
[53] Valérie Lallemand-Breitenbach et al. Pml nuclear bodies. Cold Spring Harbor perspec-
tives in biology, 2(5):a000661, 2010.
[54] Elizabeth C Batty, Kirsten Jensen, and Paul S Freemont. Pml nuclear bodies and
other trim-defined subcellular compartments. TRIM/RBCC Proteins, pages 39–58,
2012.
[55] Mario Cioce and Angus I Lamond. Cajal bodies, a long history of discovery. Annu.
Rev. Cell Dev. Biol., 21:105–131, 2005.
[56] Anthony A Hyman and Clifford P Brangwynne. Beyond stereospecificity: liquids and
mesoscale organization of cytoplasm. Developmental cell, 21(1):14–16, 2011.
107
[57] Sudeep Banjade and Michael K Rosen. Phase transitions of multivalent proteins can
promote clustering of membrane receptors. Elife, 3:e04123, 2014.
[58] Pilong Li, Sudeep Banjade, Hui-Chun Cheng, Soyeon Kim, Baoyu Chen, Liang Guo,
Marc Llaguno, Javoris V Hollingsworth, David S King, Salman F Banani, et al. Phase
transitions in the assembly of multivalent signalling proteins. Nature, 483(7389):336–
340, 2012.
[59] Salman F. Banani, Hyun O. Lee, Anthony A. Hyman, and Michael K. Rosen. Biomolec-
ular condensates: organizers of cellular biochemistry. Nature Reviews Molecular Cell
Biology, 18:285–298, 2017.
[60] Meiyan Jin, Gregory G. Fuller, Ting Han, Yao Yao, Amelia F. Alessi, Mallory A.
Freeberg, Nathan P. Roach, James J. Moresco, Alla Karnovsky, Misuzu Baba, John R.
Yates, Aaron D. Gitler, Ken Inoki, Daniel J. Klionsky, and John K. Kim. Glycolytic
enzymes coalesce in g bodies under hypoxic stress. Cell Reports, 20(4):895–908, 2017.
ISSN 2211-1247. doi: https://doi.org/10.1016/j.celrep.2017.06.082. URL https://
www.sciencedirect.com/science/article/pii/S2211124717309300.
[61] J.B. Woodruff, B. Ferreira Gomes, P.O. Widlund, J. Mahamid, A. Honigmann,
and A.A. Hyman. The centrosome is a selective condensate that nucleates micro-
tubules by concentrating tubulin. Cell, 169(6):1066–1077.e10, 2017. doi: 10.1016/
j.cell.2017.05.028. URL https://www.scopus.com/inward/record.uri?eid=2-s2.
0-85020053848&doi=10.1016. cited By 240.
[62] Amayra Hernández-Vega, Marcus Braun, Lara Scharrel, Marcus Jahnel, Susanne Weg-
mann, Bradley T. Hyman, Simon Alberti, Stefan Diez, and Anthony A. Hyman. Local
nucleation of microtubule bundles through tubulin concentration into a condensed




[63] S. Gueroussov, R.J. Weatheritt, D. O’Hanlon, Z.-Y. Lin, A. Narula, A.-C. Gingras,
and B.J. Blencowe. Regulatory expansion in mammals of multivalent hnrnp assemblies
that globally control alternative splicing. Cell, 170(2):324–339.e23, 2017. doi: 10.1016/
j.cell.2017.06.037. URL https://www.scopus.com/inward/record.uri?eid=2-s2.
0-85023645460&doi=10.1016. cited By 55.
[64] M. Arrasate, S. Mitra, E.S. Schweitzer, M.R. Segal, and S. Finkbeiner. Inclusion body
formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature,
431(7010):805–810, 2004. doi: 10.1038/nature02998. URL https://www.scopus.com/
inward/record.uri?eid=2-s2.0-7244236320&doi=10.1038. cited By 1524.
[65] Claudia M. Cremers, Daniela Knoefler, Stephanie Gates, Nicholas Martin, Jan-Ulrik
Dahl, Justine Lempart, Lihan Xie, Matthew R. Chapman, Veronica Galvan, Daniel R.
Southworth, and Ursula Jakob. Polyphosphate: A conserved modifier of amyloidogenic
processes. Molecular Cell, 63(5):768–780, 2016. ISSN 1097-2765. doi: https://doi.
org/10.1016/j.molcel.2016.07.016. URL https://www.sciencedirect.com/science/
article/pii/S1097276516303690.
[66] Edward W.J. Wallace, Jamie L. Kear-Scott, Evgeny V. Pilipenko, Michael H. Schwartz,
Pawel R. Laskowski, Alexandra E. Rojek, Christopher D. Katanski, Joshua A. Riback,
Michael F. Dion, Alexander M. Franks, Edoardo M. Airoldi, Tao Pan, Bogdan A.
Budnik, and D. Allan Drummond. Reversible, specific, active aggregates of endogenous
proteins assemble upon heat stress. Cell, 162(6):1286–1298, 2015. ISSN 0092-8674. doi:
https://doi.org/10.1016/j.cell.2015.08.041. URL https://www.sciencedirect.com/
science/article/pii/S0092867415010934.
[67] Mylene C Ferrolino, Diana M Mitrea, J Robert Michael, and Richard W Kriwacki.
Compositional adaptability in npm1-surf6 scaffolding networks enabled by dynamic
switching of phase separation mechanisms. Nature communications, 9(1):1–11, 2018.
[68] Hanieh Falahati, Bobbie Pelham-Webb, Shelby Blythe, and Eric Wieschaus. Nucle-
109
ation by rrna dictates the precision of nucleolus assembly. Current Biology, 26(3):
277–285, 2016.
[69] Alice Grob and Brian McStay. Construction of synthetic nucleoli and what it tells us
about propagation of sub-nuclear domains through cell division. Cell cycle, 13(16):
2501–2508, 2014.
[70] Diana M Mitrea, Jaclyn A Cika, Clifford S Guy, David Ban, Priya R Banerjee, Christo-
pher B Stanley, Amanda Nourse, Ashok A Deniz, and Richard W Kriwacki. Nucle-
ophosmin integrates within the nucleolus via multi-modal interactions with proteins
displaying r-rich linear motifs and rrna. eLife, 5:e13571, feb 2016. ISSN 2050-084X.
doi: 10.7554/eLife.13571. URL https://doi.org/10.7554/eLife.13571.
[71] Mikael S Lindström. Npm1/b23: a multifunctional chaperone in ribosome biogenesis
and chromatin remodeling. Biochemistry research international, 2011, 2011.
[72] Ludmila G Romanova, Martin Anger, Olga V Zatsepina, and Richard M Schultz. Im-
plication of nucleolar protein surf6 in ribosome biogenesis and preimplantation mouse
development. Biology of reproduction, 75(5):690–696, 2006.
[73] Kensaku Murano, Mitsuru Okuwaki, Miharu Hisaoka, and Kyosuke Nagata. Tran-
scription regulation of the rrna gene by a multifunctional nucleolar protein,
b23/nucleophosmin, through its histone chaperone activity. Molecular and Cellular
Biology, 28(10):3114–3126, 2008. doi: 10.1128/MCB.02078-07.
[74] Leonard B. Maggi, Michael Kuchenruether, David Y. A. Dadey, Rachel M. Schwope,
Silvia Grisendi, R. Reid Townsend, Pier Paolo Pandolfi, and Jason D. Weber. Nu-
cleophosmin serves as a rate-limiting nuclear export chaperone for the mammalian
ribosome. Molecular and Cellular Biology, 28(23):7050–7065, 2008. doi: 10.1128/
MCB.01548-07.
[75] Casey Lee, Brian A Smith, Keya Bandyopadhyay, and Ruth A Gjerset. Dna damage
110
disrupts the p14arf-b23 (nucleophosmin) interaction and triggers a transient subnuclear
redistribution of p14arf. Cancer research, 65(21):9834–9842, 2005.
[76] Daniel D. Scott and Marlene Oeffinger. Nucleolin and nucleophosmin: nucleolar
proteins with multiple functions in dna repair. Biochemistry and Cell Biology, 94
(5):419–432, 2016. doi: 10.1139/bcb-2016-0068. URL https://doi.org/10.1139/
bcb-2016-0068. PMID: 27673355.
[77] Diana M. Mitrea, Christy R. Grace, Marija Buljan, Mi-Kyung Yun, Nicholas J. Pytel,
John Satumba, Amanda Nourse, Cheon-Gil Park, M. Madan Babu, Stephen W. White,
and Richard W. Kriwacki. Structural polymorphism in the n-terminal oligomerization
domain of npm1. Proceedings of the National Academy of Sciences, 111(12):4466–4471,
2014. ISSN 0027-8424. doi: 10.1073/pnas.1321007111. URL https://www.pnas.org/
content/111/12/4466.
[78] Jose M Eirin-Lopez, Lindsay J Frehlick, and Juan Ausio. Long-Term Evolution and
Functional Diversification in the Members of the Nucleophosmin/Nucleoplasmin Fam-
ily of Nuclear Chaperones. Genetics, 173(4):1835–1850, 08 2006. ISSN 1943-2631.
doi: 10.1534/genetics.106.058990. URL https://doi.org/10.1534/genetics.106.
058990.
[79] Anastasiia Moraleva, Charalambos Magoulas, Mikhail Polzikov, Sabine Hacot,
Hichem C Mertani, Jean-Jacques Diaz, and Olga Zatsepina. Involvement of the specific
nucleolar protein surf6 in regulation of proliferation and ribosome biogenesis in mouse
nih/3t3 fibroblasts. Cell Cycle, 16(20):1979–1991, 2017.
[80] Miharu Hisaoka, Kyosuke Nagata, and Mitsuru Okuwaki. Intrinsically disordered re-
gions of nucleophosmin/B23 regulate its RNA binding activity through their inter- and
intra-molecular association. Nucleic Acids Research, 42(2):1180–1195, 10 2013. ISSN
0305-1048. doi: 10.1093/nar/gkt897. URL https://doi.org/10.1093/nar/gkt897.
[81] J.L. Camberg, S.M. Doyle, D.M. Johnston, and S. Wickner. Molecular chaper-
111
ones. In Stanley Maloy and Kelly Hughes, editors, Brenner’s Encyclopedia of
Genetics (Second Edition), pages 456–460. Academic Press, San Diego, second
edition edition, 2013. ISBN 978-0-08-096156-9. doi: https://doi.org/10.1016/
B978-0-12-374984-0.00221-7. URL https://www.sciencedirect.com/science/
article/pii/B9780123749840002217.
[82] Martina Beissinger and J Buchner. How chaperones fold proteins. Biological chemistry,
379(3):245–259, 1998.
[83] Catalin M. Filipeanu. Chapter eleven - temperature-sensitive intracellular traffic of
alpha2c-adrenergic receptor. In Guangyu Wu, editor, Trafficking of GPCRs, vol-
ume 132 of Progress in Molecular Biology and Translational Science, pages 245–
265. Academic Press, 2015. doi: https://doi.org/10.1016/bs.pmbts.2015.02.008. URL
https://www.sciencedirect.com/science/article/pii/S187711731500037X.
[84] Takaho Terada and Shigeyuki Yokoyama. Chapter thirteen - escherichia coli cell-
free protein synthesis and isotope labeling of mammalian proteins. In Zvi Kelman,
editor, Isotope Labeling of Biomolecules - Labeling Methods, volume 565 of Methods
in Enzymology, pages 311–345. Academic Press, 2015. doi: https://doi.org/10.1016/
bs.mie.2015.08.035. URL https://www.sciencedirect.com/science/article/pii/
S0076687915005029.
[85] R.B. Wickner, H. Edskes, T. Nakayashiki, F. Shewmaker, L. McCann, A. En-
gel, and D. Kryndushkin. Prions of yeast and fungi. In Brian W.J. Mahy and
Marc H.V. Van Regenmortel, editors, Encyclopedia of Virology (Third Edition),
pages 336–341. Academic Press, Oxford, third edition edition, 2008. ISBN 978-0-
12-374410-4. doi: https://doi.org/10.1016/B978-012374410-4.00407-6. URL https:
//www.sciencedirect.com/science/article/pii/B9780123744104004076.
[86] A.J.L. Macario and E. Conway de Macario. Chaperone proteins and chaperonopathies.
In George Fink, editor, Encyclopedia of Stress (Second Edition), pages 438–444.
112
Academic Press, New York, second edition edition, 2007. ISBN 978-0-12-373947-
6. doi: https://doi.org/10.1016/B978-012373947-6.00075-1. URL https://www.
sciencedirect.com/science/article/pii/B9780123739476000751.
[87] Mark R. Woodford, Diana Dunn, Jonelle B. Miller, Sami Jamal, Len Neckers, and
Mehdi Mollapour. Chapter two - impact of posttranslational modifications on the
anticancer activity of hsp90 inhibitors. In Jennifer Isaacs and Luke Whitesell, ed-
itors, Hsp90 in Cancer: Beyond the Usual Suspects, volume 129 of Advances in
Cancer Research, pages 31–50. Academic Press, 2016. doi: https://doi.org/10.1016/
bs.acr.2015.09.002. URL https://www.sciencedirect.com/science/article/pii/
S0065230X15000949.
[88] Daniel Jeffery, Katrina Podsypanina, Tejas Yadav, and Geneviève Almouzni. Chro-
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A.1 Binding affinity parameter
We have some unknown parameters in grand partition function of zipper molecules. To
facilitate the comparison of our theory with experiment, we have to reduce these number of
unknown parameters.








where Ztrans = V is total volume of system, Zmomentum = λ
−3 where λ is the de Broglie
wavelength and Zint = ZrotZelec.....




Total free energy for a system of N molecules,
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∴ logKd = ∆F + F0 (A.5)








Table A.1: Scaffold Dis-
sociation constant




TableA.1 shows the experimental data for polySUMO-polySIM dissociation constant for
different scaffold valency. The fitted value of unknown parameter through Eq.A.5 using
experimental data [TableA.1] are ε = −2.23KBT and F0 = −9.4KBT . With these two values











After getting fitted value of ε and F0, we have an unknown parameter left. It is client-
scaffold binding affinity. We have taken appropriate value of client-scaffold binding affinity







Table A.2: Client binding
affinity
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A.2 End Vectors and Transfer Matrices
Total grand partition function (Eq. 2.10) of the system is:

















The two summation terms represent filaments starting with SUMO or SIM modules.
In our formalism, filaments begin at the right end and grow right to left by application
of the transfer matrices. The starting vectors VUR and VIR initiate the assembly with an
imperfectly aligned dimer. These dimers have v− 1 different states where v is the valence of
the scaffolds. These states have free energy e−(v−n)εgi(n) where n = 1, 2, 3....v− 1, and gi(n)
is the gap partition function for the sticky end defect at right end of the filament. These





























VUR and VIR are identical apart from the client species that can bind in the gap partition
functions gU and gI, where the gap partition functions are labeled with subscripts that
describe the client that they bind.
The transfer matrix Mi for deccavalent (v = 10) scaffolds is given by

0 0 0 0 0 0 0 0 zie
−9ε
0 0 0 0 0 0 0 zie
−8ε zie
−8εgi(1))


















































Where zi is the fugacity of the attached molecule and gi(n) is the gap partition function for
a gap of n unbound modules. Again, the matrices MU and MI are identical apart from the
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fugacity of the added molecule and the client species that binds in the gap. Since adding
a SUMO molecule will leave a gap of unbound SIM modules, the gap partition function gU
describes the binding of clients composed of SUMO modules.
Applying N transfer matrices to the right vector generates a vector V(N + 2) describing
a filament containing N + 2 scaffold molecules. Each element of the vector is a polynomial
giving the partition function of a filament terminating with a different length sticky end.
The left vectors, ViL, serve three purposes. First, they collapse the filament vector into a
scalar polynomial that gives the complete partition function of the filament. Secondly, the
left vector provides the statistical weights for client binding at the left sticky end. These two
functions can be served by a vector of the form
Vi = {gi(1), gi(2), gi(3), gi(4), gi(5), gi(6), gi(7), gi(8), gi(9)}
The third function of the left vector is that it must account for the fact that a filament
can terminate with either species of scaffold. That means that the final left vectors are given
by
VUL = VU + VIMU (A.11)
VIL = VI + VUMI (A.12)
A.3 Monomer Concentration vs total concentration
The quantities cU and cI appearing in our calculations represent the concentration of scaffold
molecules that have not formed intermolecular bonds. In contrast, the more experimentally
accessible quantity is the total scaffold concentration Ctot, which includes molecules that










Fig 2.16 plots the free scaffold concentrations as a function of the total SUMO module
concentration. There are several observations to make from this plot. First, when the scaffold
concentrations are equal the monomer concentrations are very low, on the order of 10−10 M.
This is much lower than the dilute phase concentration reported by7. The discrepancy is due
to the fact that most molecules in the dilute phase are in the perfectly aligned dimer state.
This state satisfies all the available bonding sites, rendering the scaffolds inert to further
assembly processes.
Second, when one scaffold is in excess, SUMO in this case, the monomer concentrations
diverge widely (note the logarithmic vertical axis). This is because the low concentration
scaffolds are mostly consumed in complexes with the higher concentration module. The
depletion of low concentration modules results in an excess of high concentration modules
that increases as the stoichiometry asymmetry increases.
Third, it is useful to compare the concentrations in Fig 2.16 to the 105 M−1 affinity for
monovalent SUMO-SIM binding7. At equal scaffold stoichiometry, the scaffold monomer
concentrations are much too low for monovalent binding to occur. This justifies our ap-
proximation of strictly 1D filament formation because most of the gaps only have one or two
unbound sites. However, when the SUMO module concentration reaches 90 µM (a 9:5 excess
over SIM), the concentration of free SUMO module scaffolds is ' 14 µM. This is comparable
to the ' 0.1 µM concentration of clients, so monovalent binding cannot be neglected.
A.4 Excess monomer scaffold binding at defect sites
When the scaffolds are present at unequal stoichiometries, the excess scaffold accumulates
at concentrations where monovalent binding in the gaps becomes significant. At large asym-
metry, the excess scaffold monomer concentration (' 1 µM) is about ten times greater than
the total client concentration (' 0.1 µM) so that monomer scaffold binding is more favorable
than client binding at defect sites. Therefore, we need to correct our 1D filament model to
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Figure 1: Excess monomer scaffold concentration binding at defect sites in crosslinked fash-
ion.
allow for perpendicular binding of scaffolds. As a first correction, we consider the “t” con-
figuration illustrated in Fig. 1. This correction only allows for monovalent binding, which
we expect to dominate given the small size of gaps in the filament.






Where K1a = 10
5 M−1 is the monovalent SUMO-SIM binding affinity7. This affinity is
multiplied by a factor of 10 to account for the degeneracy of binding of a decavalent scaffold





is the concentration of SIM defects in the network droplet. The latter quantity is calculated
from the concentration of SIM scaffolds in the droplets, cdropletI
7, and the density of defect
sites per SIM scaffold, which is calculated from ρIg = N
−1
tot gU∂ lnQdroplet/∂gU, where we have
used the substitution gU(m) = g
m
U to define gU as the statistical weight of an unbound
SIM module. Again, the subscript follows from our definition of gap partition functions
based on the client that they bind. Note that this correction has not been applied to our
PC calculations, which explains the systematic underestimate of the PC at high SUMO
concentration.
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